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Introduction 
Although it has been reported in 1929 that food may affect blood pressure [1], it 
has been recognized for only a few years that ingestion of food can substantially 
lower blood pressure. 
Grollman reported that in young healthy subjects, systolic blood pressure slightly 
rises after the ingestion of food, whereas diastolic blood pressure remains con-
stant or slightly falls [1]. In patients with autonomic dysfunction, Robertson et al 
found in 1981 a marked fall in both systolic and diastolic blood pressure after a 
meal [2]. In addition, in 1983 Lipsitz et al evaluated the effects of a meal on systo-
lic blood pressure in institutionalized elderly subjects aged 75 - 98 years and 
found a decline in systolic blood pressure by 25 mm Hg [3]. These investigators 
suggested that postprandial reductions in blood pressure may constitute a cause of 
postprandial syncope. Postprandial hypotension as a clinical problem was first 
reported in 1977 by Seyer-Hansen [4]. He described a 65 year old man with par-
kinsonism who suffered of severe dizziness and visual disturbances during almost 
every meal. In this patient, large falls in blood pressure were measured after a meal 
and after ingestion of oral glucose. Remarkably, plasma insulin levels were very 
high after the ingestion of oral glucose. 
Postprandial blood pressure reduction 
In view of the high frequency of syncopal episodes observed after breakfast in 
elderly institutionalized patients, Lipsitz and colleagues evaluated the effect of a 
standardized 384 Kcal breakfast on blood pressure in elderly subjects with and 
without a history of syncope [3]. By 35 minutes after the meal, mean systolic 
blood pressure had declined by 25 ± 5 mm Hg in ten elderly subjects with syn-
cope and 24 ± 9 mm Hg in ten elderly subjects without syncope. There was no 
significant change in pulse rate in both groups of subjects, which suggested an 
impaired baroreflex compensation for the hypotensive effects of eating. The 
hypotensive effects of a meal were also studied in healthy elderly subjects who 
were without apparent cardiovascular disease and not taking any medication with 
an influence on the cardiovascular system [5]. In this group, with a mean age 80 ± 
6 years, blood pressure declined from 151/72 to 139/61 mm Hg at 50 min after the 
start of a breakfast. Heart rate increased significantly. Lipsitz et al confirmed that 
blood pressure also declines in healthy elderly people living in the community [6]. 
In addition, they found that blood pressure reduction after a noon-meal and after 
breakfast were of a comparable magnitude. Both studies found a significant 
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inverse correlation between postprandial and baseline blood pressure. In healthy 
young subjects the ingestion of food has virtually no effect on blood pressure: 
supine systolic blood pressure remains more or less constant whereas supine 
diastolic blood pressure slightly decreases [3,5,7,8]. 
Clinical significance 
Falling is among the most serious problems facing the ageing population and may 
have great consequences for morbidity (hip fractures), mortality and the cost of 
health care. 
With advancing age, there is a progressive decline in homeostatic capacity, so that 
the elderly have a blunted ability to adapt to hypotensive stress [9]. The superim-
position of drugs and disease may further impair blood pressure regulation. The-
refore, additional declines in blood pressure after a meal may become clinically 
important because of dizziness, syncope and falling. Falls related to hypotension 
are often clinically presented as a syncope [9]. Although postprandial blood pres-
sure reductions are in most cases only modest, it should be noted that in the 
elderly also minor systemic falls in blood pressure after eating may cause symp-
toms of cerebral ischemia due to a defect of vascular autoregulation [10]. 
Syncope, defined as a sudden temporary loss of consciousness associated with loss 
of postural tone, is a common symptom in elderly people and remains unexplai-
ned in 30 - 50% of all cases [11,12]. It has been reported that syncope in the 
elderly has a one year mortality of 6 - 19% and a two years mortality of 27% 
[12,13]. The view that syncope may be associated with serious morbidity is sup-
ported by a study by Brocklehurst et al who show that nearly 20% of falls resul-
ting in hip fractures in the elderly were due to fainting [14]. 
In a prospective study among institutionalized elderly people aimed at identifying 
causes of syncope, Lipsitz et al found that in 31 of 97 syncope patients, the fain-
ting occurred during a meal or within one hour thereafter [11]. In eight of these 
subjects, with syncope within one hour of eating, hypotension was documented 
immediately upon fainting. By 60 min after a meal, mean arterial pressure had 
declined with an average of 26 mm Hg in these patients in contrast to a decline of 
9 mm Hg in nonsyncopal elderly controls [15]. Although the clinical significance 
of postprandial hypotension in the elderly remains to be elucidated, it seems likely 
that the combination of a decrease in blood pressure after a meal with or without 
common hypotensive stimuli such as medications, postural change or a valsalva 
maneuver during voiding, can result in a predisposition to syncope and falls. 
Pathophysiology 
Several hypotheses have been proposed to explain the pathophysiological mecha-
nisms of postprandial blood pressure reduction in the elderly. 
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1 Decreased cardiac output 
Splanchnic blood pooling after a meal might reduce venous blood return to the 
heart and thereby decrease stroke volume and cardiac output resulting in a fall in 
blood pressure. In young subjects it was found that heart rate and cardiac output 
rise while stroke volume does not change or increase after a meal. Total systemic 
resistance decreases after a meal but increases were observed in forearm vascular 
resistance [7,16]. Hoeldtke et al performed a cardiac catheterization m a 70 year 
old patient with autonomic neuropathy who became dizzy following a meal [17J. 
Food ingestion caused a profound drop in both systolic and diastolic blood pres-
sure by 40 - 80 mm Hg and a prompt lowering of systemic vascular resistance, but 
stroke volume and cardiac output remained unchanged. Although it is hazardous 
to generalize these results from a single patient, it seems likely that the modest 
postprandial blood pressure decline as seen in healthy elderly subjects is not a 
result of decreased cardiac output. 
2 Autonomic dysfunction 
Postprandial hypotension in the elderly might be due to an inadequate sympathe-
tic compensation for the meal induced shifts of blood volume into the splanchnic 
system, with an attendant decrease in central blood volume 
Even in extreme old age, homeostasis may still be maintained under resting condi-
tions, but when the organism is subjected to stress disturbances of physiological 
balance may readily occur and the time for recovery is usually prolonged [18,19]. 
Both the neural and endocrine systems play a major role in regulating the reac-
tions of the organism to changes in the environment and it seems likely that 
impairment in function of the autonomic nervous system makes a major contribu-
tion to the decline in efficiency of homeostatic regulation. 
However, it still remains controversial whether the function of the autonomic 
nervous system declines with age. An increase of sympathetic nervous system 
activity with advancing age has been proposed because of the higher baseline 
plasma norepinephrine values in the elderly and because of the finding that the 
number of impulses at the sympathetic nerve endings into the muscles increased 
with age [20]. In addition to these findings, increased plasma norepinephrine 
levels have been observed in older subjects during upright posture [21,22,23] as 
well as following oral glucose ingestion [23] In contrast, another group found 
that sympathetic nervous system activity in the ins of the eye declined with age 
124]. 
The activity of the sympathetic nervous system with advancing age remains diffi-
cult to determine because of many problems complicating the measurements 
Firstly, the activity of the sympathetic nervous system is mostly derived from 
changes in plasma norepinephrine Plasma norepinephrine reflects the norepi-
nephrine that reaches the systemic circulation and represents a small fraction of 
that which is released. Furthermore, both neuronal release and clearance of nore 
pinephrine from plasma arc different for most organs as has been demonstrated by 
3 
regional norepinephrine turnover studies [25]. Direct microneurography of nerve 
fascicles, arterial sampling or kinetic studies for regional norepinephrine measure-
ment are not feasible in large groups of elderly subjects. Despite all these handi-
caps, it was recently concluded that the measurement of venous plasma concen-
tration of norepinephrine provides a useful guide to sympathetic nervous system 
activity to detect generalized changes [26]. Secondly, it is generally agreed that 
plasma norepinephrine increases with age, but it remains to be determined whe-
ther this is due to a reduced clearance of norepinephrine [26] or to an increased 
rate of neuronal release [27]. In addition, Hoeldtke et al reported that in the 
elderly the rate at which norepinephrine enters the circulation is increased, but 
that norepinephrine production is normal [28]. 
Finally, the response of the target organ not only depends on sympathetic nervous 
system activity and the concentration of neurotransmitters but also on the reacti-
vity of the receptors since an age-related decrease in /3-adrenoreceptor sensitivity 
has been demonstrated [29]. An important limitation which should be kept in 
mind is that the sympathetic outflow to all organs is not uniform, and regional, 
organ-specific increases or decreases in sympathetic nervous system activity can 
occur with different reflexes and in different disease states [26]. 
An age related increase of sympathetic nervous system activity may be compensa-
tory to a decline in baroreceptor function [24]. The baroreceptor reflex is an 
important element in the autonomic control of the circulation and serves to mini-
mize wide fluctuations in blood pressure [30]. An impairment of baroreflex func-
tion would result in less tonic inhibition of the vasomotor centre. As a result, effe-
rent signals to the heart and vascular smooth muscle would be altered in order to 
decrease parasympathetic nervous system activity and increase cardiac and vascu-
lar sympathetic nervous system activities, resulting in increased spillover of nore-
pinephrine into plasma. Therefore it has been postulated that ageing in man may 
be accompanied by a generalized decrease of autonomic nervous system function, 
but that an impaired baroreceptor mechanism leads to a compensatory increase of 
cardiovascular sympathetic nervous system activity, which masks the underlying 
functional defect [24]. 
Age and hypertension reduce baroreflex sensitivity independently of each other 
[31,32,33]. On top of that, insulin secretion following a meal may play a role by 
blunting baroreflex activity [34]. Changes at any site in the baroreflex arch, inclu-
ding the loss of arterial distensibility as a consequence of higher blood pressure as 
well as age, can account for the reduced baroreflex sensitivity [19,32]. Since both 
ageing and hypertension are associated with impaired baroreflex function, hyper-
tensive elderly may have greater impairments in baroreflex function and therefore 
greater postprandial declines in blood pressure. Indeed, the relationship between 
baseline blood pressure and the decrease in blood pressure after a meal supports 
this suggestion [5,6]. 
3 Insulin 
Meal related insulin release may play a role in postprandial hypotension. Insulin 
has been recognized to exert cardiovascular effects, even in the absence of 
hypoglycemia. In diabetic patients with autonomic neuropathy systolic and 
diastolic blood pressure fell considerably after insulin administration [35,36]. This 
effect was aggravated by tilting to the vertical position. The hypotensive effect of 
insulin occurs irrespective whether it is administered intravenously, intramuscu-
larly or subcutaneously. In subjects with normal baroreceptor reflexes, however, 
blood pressure was only slightly affected after intravenous insulin in the supine 
position, although in the upright position the fall in blood pressure was more 
marked after insulin administration [35]. Also other studies report that in patients 
with chronic autonomic failure and in diabetic patients, intravenous insulin admi-
nistration caused a decrease of blood pressure and even hypotension and syncope 
[4,37,38,39]. In addition, Lipsitz et al found evidence for an association between 
insulin therapy and syncope in institutionalized elderly subjects [11]. In this study 
it was shown that insulin therapy increased the risk of developing syncope by 
29%. However, although an independent correlation between insulin therapy and 
syncope could be demonstrated, no association existed between insulin therapy 
and meal-related syncope. 
Several studies demonstrated that insulin infusions in conscious dogs resulted in a 
vasodilator effect on skeletal muscle vasculature [40,41]. In addition, intra-arterial 
infusion of insulin in the forearm of healthy young volunteers causes an increase 
in forearm blood flow and a decrease in forearm vascular resistance [42]. A possi-
ble explanation for the vasodilation could be an antagonistic action of insulin and 
norepinephrine. In several studies, insulin has been found to inhibit the vasocon-
striction induced by norepinephrine [43,44,45], and to facilitate the re-uptake of 
norepinephrine at the nerve terminals [46]. 
On the other hand, insulin infusion increases sympathetic nervous system activity 
in the absence of changes in blood glucose in young volunteers [47], in diabetic 
patients without neuropathy [48] and in dogs [40]. In the elderly, however, no 
change in norepinephrine, as a measure of sympathetic nervous system activity, 
was found in response to insulin [49] and it was therefore suggested that postpran-
dial hypotension may in part reflect a failure of sympathetic nervous system acti-
vation [3]. A decreased stimulation of the sympathetic nervous system by insulin 
was also found in diabetic patients with autonomic neuropathy [48]. This seems to 
support the aforementioned hypothesis. 
Finally, eating may affect blood pressure homeostasis in the elderly through insu-
lin-induced blunting of baroreflex sensitivity [3]. This suggestion was based on 
the findings of Appenzeller et al who found that oral glucose decreased barore-
ceptor response to the Valsalva manoeuver in young and old patients with cere-
brovascular disease or peripheral neuropathy [34]. Additional support for a 
decreased sensitivity of baroreceptor function by insulin was derived from some 
other studies [35,36]. Miles et al demonstrated that head-up tilting after intrave-
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nous insulin administration in normal and diabetic subjects resulted in a greater 
fall in mean arterial pressure than during tilting without insulin [35]. Similar 
results were found by Page et al who studied diabetic patients with autonomic 
neuropathy [36]. Although baroreflex sensitivity was not measured in these stu-
dies, Lipsitz et al concluded that insulin administration impaired baroreflex 
mechanisms [3]. 
4 Vasodilating hormones 
Food ingestion may stimulate the secretion of gastrointestinal vasoactive hormo-
nes or substances which may affect blood pressure. In elderly subjects, with insuf-
ficient compensatory mechanisms of the sympathetic nervous system, the effects 
on systemic circulation may become apparent by a decrease of blood pressure. On 
the other hand, the secretion of gastrointestinal hormones may increase with 
advancing age or disease. This has, for instance, been demonstrated for pancreatic 
polypeptide of which the level was significantly higher in the elderly than in 
young subjects after an oral glucose load [50]. In addition, neurotensin levels rose 
to a greater extent after a meal in patients with autonomic failure than in young 
healthy subjects [16]. There may, therefore, be a role for gut peptides in postpran-
dial blood pressure reduction, although this effect may be limited to local or 
regional effects, i.e. splanchnic vasodilation. Indeed, attenuation or even preven-
tion of postprandial hypotension has been demonstrated with somatostatin [51], 
which inhibits the secretion of almost all gastrointestinal hormones [52]. Also 
other vasodilating substances may be involved in the postprandial fall of blood 
pressure. It has been shown that both indomethacin and caffeine attenuated the 
blood pressure reduction following a meal in patients with autonomic failure 
[2,53]. Indomethacin inhibits prostaglandin synthesis and the effect of caffeine 
may be due to antagonism of an adenosine-mediated vasodilation. 
J Contraction in plasma volume 
Another theory, that has been offered to explain postprandial blood pressure 
reduction, is a shift of water and electrolytes to the lumen of the small intestine 
induced by hyperosmolar food with subsequent hemoconcentration and decrea-
sed circulating blood volume. Furthermore, Gunderson and Christensen showed 
that intravenous insulin resulted in a decrease of plasma volume [54]. However, 
this hypothesis seems rather unlikely since Bannister et al have shown that in 
patients with autonomic failure the hematocrit remains unchanged after a break-
fast, suggesting that a contraction in plasma volume is unlikely to be responsible 
[55]. In addition, there are no changes in plasma electrolytes or osmolality [55]. 
This suggests that fluid loss, especially into the gut as a result of osmotic changes, 
is unlikely to contribute to the hypotension. 
In conclusion, it may be supposed that one or more of the aforementioned mecha-
nisms are involved in postprandial blood pressure reduction, but the relative 
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importance of these factors to the pathophysiology of this phenomenon remains 
unknown. 
Outline of the studies 
Postprandial blood pressure reduction is associated with age and hypertension. 
Because many elderly patients are treated with antihypertensive drugs, we won-
dered whether these drugs may increase the postprandial blood pressure reduc-
tion, since these drugs interfere with blood pressure homeostasis. Chapter I and II 
describe studies on the influence of antihypertensive treatment with different 
drugs on the extent of the postprandial fall in blood pressure. 
To elucidate the role of insulin, we studied the effects of oral glucose versus oral 
fructose loading on blood pressure in young and old subjects with different blood 
pressure levels. In contrast to glucose, fructose loading elicits only a small increase 
in plasma insulin levels (chapter III). 
To determine whether the hypotensive effect of glucose loading is mediated by 
gastrointestinal factors or by the vasodilator properties of insulin we compared 
the effects of oral and intravenous glucose loading on blood pressure (chapter IV). 
Since insulin may affect baroreflex function we studied the influence of oral glu-
cose loading on baroreflex sensitivity in the elderly (chapter V). 
Whether the postprandial decline in blood pressure is specifically related to the 
ingestion of carbohydrate and not of fat or protein was investigated in a study 
described in chapter VI. 
Finally, to investigate whether vasoactive gut hormones play a role in the decline 
of blood pressure after oral glucose loading, we studied the effects of a somatosta-
tin analogue octreotide (SMS 201-995) on the course of blood pressure after oral 
glucose with and without the administration of insulin (chapter VII and VIII). 
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CHAPTER I 
Antihypertensive treatment and postprandial 
blood pressure reduction in the elderly 
Abstract 
Recently it has been demonstrated that blood pressure in the elderly decreases 
after a meal. To evaluate the influence of antihypertensive treatment on postpran-
dial blood pressure reduction in the elderly, the effects of a breakfast (405 kcal) on 
blood pressure and heart rate were studied in 15 healthy normotensive elderly 
subjects (mean age 79.5 ± 6.0 years), in 10 healthy hypertensive elderly subjects 
(mean age 80.2 ± 5.7 years) and in 22 hypertensive elderly subjects (mean age 71.4 
± 5.0 years) treated with antihypertensive medication (diuretics, /S-blockers, 
vasodilators). In the three groups there was a fall of mean arterial blood pressure 
of 9.3 ± 1.9%, 13.8 ± 1.9% and 7.9 ± 1.3%, respectively, at 40 min after the start 
of the breakfast. In all three groups heart rate increased significantly. It is conclu-
ded that antihypertensive treatment with the regimens used in this study does not 
induce an additional fall of blood pressure postprandially. However, the influence 
of eating should be avoided in the assessment of antihypertensive drug effects in 
the elderly. 
Introduction 
Recently it has been demonstrated that elderly subjects frequently show a fall in 
blood pressure (BP) after a meal. This was found both in ill institutionalized 
patients on long-term medication [6] and in healthy noninstitutionalized subjects, 
not taking any medication with an influence on the cardiovascular system [5,8]. In 
healthy young subjects, BP remains unchanged after a meal [8]. 
Treatment with antihypertensive drugs may cause an exacerbation of the post-
prandial BP reduction in the elderly, since these drugs interfere with BP homeo-
stasis [3,4]. Therefore, we studied the effects of a meal on BP and heart rate in 
healthy elderly people who were treated with various types of antihypertensive 
drugs. 
Subjects and Methods 
For this study 22 elderly patients with antihypertensive treatment (Eld-med) were 
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randomly selected from the outpatient clinic of the Department of Medicine of 
the St. Radboud University Hospital, Nijmegen. 
AU patients were over 65 years, healthy and living independently in the communi-
ty. Patients with the following diseases were excluded from the study: myocardial 
infarction, congestive heart failure, cerebrovascular accident, diabetes mellitus, 
chronic respiratory disease, malignancy and mental deterioration. All patients 
were on hypertensive treatment. Seven patients used a diuretic (hydrochlorothia-
zide, dose range 25-50 mg, or a combination of hydrochlorothiazide and amilori-
de), 7 patients used a /3-blocker (metoprolol, dose range 50-200 mg; propranolol, 
dose 320 mg; atenolol, dose range 50-100 mg; or Oxprenolol, dose 320 mg) and 8 
patients used a combination of diuretics and /3-blockers with (n=5) or without 
(n = 3) a vasodilator (endralazine, dose 5 mg; Captopril, dose 100 mg; or hydralazi-
ne, dose range 150-200 mg). There was no difference in the mean age in the three 
subgroups. 
For comparison, 25 apparently healthy elderly subjects over 65 years, without a 
history of hypertension, were selected from a total of 432 elderly subjects living in 
the community. Exclusion criteria, as mentioned above, also applied to this 
group. Ten subjects appeared to have a high BP (BP over 160/95 mm Hg, Eld-
HT) determined by measuring BP twice, after 30 min of rest in the supine posi-
tion. Fifteen subjects had a normal BP (Eld-NT). The characteristics of the three 
groups are presented in Tabic 1. The Eld-med were significantly (p<0.001) youn-
ger than Eld-NT and Eld-HT. The Quetelet indices in the three groups did not 
differ significantly. BP of Eld-NT were significantly lower than those of Eld-HT 
and Eld-med (p<0.001). BP of Eld-med, presented in Table 1, are the mean values 
of the measurements at the last two visits at the outpatient clinic before the study. 
BP of Eld-HT and Eld-med were not significantly different. 
All studies were performed in the morning after an overnight fast. The patients on 
medical treatment did not take their morning medications. BP was measured with 
an Arteriosonde®and heart rate (HR) was calculated from an ECG-recording. 
After 20 min rest in the sitting position two readings of BP and HR after 2 min in 
the standing position were collected. After a further 5 min rest three sitting BP 
and HR readings were collected and the average was taken as the basal standing 
and sitting BP and HR. Then, at 10 min, a breakfast of 405 kcal (1,700 kj) consis-
ting of bread, butter, cheese, oatmeal porridge and orange juice (total 49 g carbo-
hydrate, 17.5 g fat and 13.4 g protein) was consumed during 15 min. BP and HR 
were measured twice at 20, 25, 30, 35, 40, 45, 50 and 55 min after the start of the 
meal and the averages of the two readings were used for analysis. After this period 
in the sitting position again two measurements were taken in the standing posi-
tion. 
For statistical analysis all data were entered on a VAX 11/780 computer and analy-
zed using statistical analysis system (SAS Inc., Cary, N.C.). Student's t test for 
paired and unpaired observations was used. Correlation coefficients were calcula-
ted according to Pearson. Mean arterial pressure (MAP) was calculated as the sum 
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Table 1 Clinical characteristics of the Eld-NT, the Eld-HT and the Eld-med 
(mean ± SD). 
Sex (malc/fcmalc) 
Age (years) mean 
range 
Quctelct (kg/mz) 
BP (mm Hg) 
Eld-NT 
(n=15) 
4/11 
79.5 + 6.0 
71-90 
27.2±4.3 
139/77±14/8 
Eld-HT 
(n=10) 
5/5 
80.2±5.7 
71-90 
26.6±3.6 
174/102±31/10 
Eld-med 
(n = 22) 
9/13 
71.4±5.0 
65-84 
26.4+2.9 
160/88 ±18/6 
of diastolic BP and one third of pulse pressure. All results are given as mean ± 
SEM, unless indicated otherwise. 
Results 
After the breakfast, MAP decreased and heart rate increased in each of the three 
groups, reaching statistical significance at each time point from 20 to 45 min (Fig 
1). Results at 40 min, when the maximum effects were observed, are presented 
here. The Eld-NT had a 5% decrease in systolic BP (142 ± 6 to 134 ± 5 mm Hg, 
p<0.01) and a 12% decrease of diastolic BP (66 ± 2 to 57 ± 2 mm Hg, p<0.003). 
The Eld-HT had a 10% decrease of systolic BP (165 ± 7 to 148 ± 7 mm Hg, 
p<0.01) and a 18% decrease of diastolic BP (82 ± 4 to 68 ± 3 mm Hg, p<0.001). 
In the Eld-med, the BP course did not show an exaggerated fall as compared to the 
postprandial decrease in BP in Eld-NT and Eld-HT. Systolic BP in Eld-med 
decreased by 5% (152 ± 4 to 145 ± 4 mm Hg, p<0.001) and diastolic BP decrea­
sed with 11% (85 ± 2 to 76 ± 2 mm Hg, p<0.001). 
Fig 2 shows the fall of MAP after the breakfast in the 3 subgroups of patients with 
different antihypertensive regimens. The postprandial MAP reductions in 
patients on a diuretic (—7%, — 7 mmHg, n=7), а/3-Ыоскег (—10%, —12 mm Hg, 
n=7) or combination therapy (— 6%, —7 mm Hg, n=8) were not significantly 
different. None of the patients in either treatment group had a potentially dange­
rous fall of BP. The greatest fall of MAP was 25 mm Hg (21%), observed in a 
patient who used a /3-blocker. 
The increments of HR in Eld-NT (+ 4 ± 3 bpm), in Eld-HT (+ 6 ± 4 bpm) and 
in the Eld-med (+ 7 ± 1 bpm) did not differ significantly. The increase of BP and 
HR after assuming the upright position before and after the breakfast is demon­
strated in Table 2. Neither before, nor after the meal, did any of the subjects have 
an orthostatic fall of systolic BP of more than 20 mm Hg. Before, but not after the 
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mean arterial pressure 
(mm Hg ) 
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heort rate 
(bpm ) 
7 0 
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t ime (mm) 
Figure 1 MAP and heart rate before and after the breakfast in Eld-NT (circles), 
Eld-HT (open triangels) and Eld-M ed (dots). 
Table 2 Changes (A) in MAP and heart rate induced by assuming the upright 
position in Eld-NT, Eld-HT and in Eld-med both before and after a standardized 
breakfast. 
Fid-NT 
Eld-HT 
Eld-med 
ДМеап arteria 
before 
breakfast 
+ I 2 4 ± 1 7 
+ 6 2 + 2 1 
+ 4 0 ± 1 3 + + 
pressure (mm Hg) 
after 
NS 
NS 
NS 
breakfast 
+ 8 7 1 0 9 
+ 9 0 ± 2 1 
+ 6 8 ± 0 7 
AHcart Rate (bpm) 
before 
breakfast 
+ 1 1 7 ± 1 4 NS 
+ 10 5±2 3 NS 
+ 8 3 ± 1 7 NS 
after 
breakfast 
+ 100±1.2 
+ 8 9 ± 1 5 
+ 8 8 ± 1 0 
p < 0 05 when compared with b Id-NT 
+ +
 p < 0 001 when compared with Eld-NT 
NS = not significant 
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Figure 2 MAP and heart rate before and after the breakfast in elderly hypertensi­
ves treated with a ß-blocker (open square), a diuretic (closed square) or combina-
tion therapy (closed triangle). 
breakfast a significant difference was found in the increase of MAP on standing, 
between Eld-NT and Eld-HT (p<0.05) and between Eld-NT and Eld-med 
p<0.001). 
Within the total group there was a significant correlation between the decrease in 
MAP at 40 min after the meal and the preprandial MAP (r=—0.42, p<0.01, 
n=47). The decrease in BP was not related to Quetclet index or to sex. 
Discussion 
This study confirms and extends the knowledge on the phenomenon of postpran-
dial BP reduction in the elderly [5,6,8]. The fall of BP after a meal may have 
important clinical implications, especially in the elderly hypertensive patients 
who are treated with antihypertensive drugs. Our first concern was a possible 
exaggerated fall of BP after a meal in elderly treated with antihypertensives. The 
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mechanism of postprandial BP reduction is still unknown, but it has been sugges-
ted that an impaired baroreflex may play an important role [6] since both age and 
hypertension are related to a decrease in baroreflex sensitivity [2]. An exaggerated 
fall might be expected from a further attenuation of baroreflex function by super-
imposition of medication Robertson et al [7], studying the effects of a meal in 
patients with autonomic dysfunction, found a decline of MAP of about 34 mm 
Hg in 6 patients who were treated with propranolol in contrast to a decline of 
about 20 mm Hg during placebo. In our study, however, we found that elderly 
patients on different types of antihypertensive treatment had a similar postpran-
dial BP reduction as hypertensive elderly without medication, although it has to 
be emphasized that the subjects in the former group were significantly younger. 
Secondly, postprandial BP reduction may interfere with the assessment of the 
effectiveness of antihypertensive treatment [1] This may lead to an overestima-
tion of the drug-induced decrease in BP. Indeed, we found in elderly hypertensi-
ves treated with various antihypertensive drugs a 5% fall of systolic and an 11% 
fall of diastolic BP at 40 mm after a breakfast. Therefore, the ingestion of food 
should be avoided during the evaluation of antihypertensive drug effects 
In all groups BP increased on standing, both before and after the breakfast. The 
magnitude of the BP increment when standing was not influenced by the test 
meal. The increase in BP in response to the upright position before the breakfast 
was significantly greater in the normotensives than in the hypertensives (with or 
without medication), probably reflecting a relative impairment of baroreflex in 
the latter groups It is remarkable, however, that standing BP increments after the 
meal did not differ significantly in the three groups. Moreover, heart rates in the 
three groups increased after the meal and on standing, demonstrating that the 
baroreflex-mediated response to these stimuli was at least not severely impaired. 
Yet, it might be that the degree of cardioacceleration was inadequate to prevent a 
postprandial BP reduction. 
A few precautions have to be taken into account with respect to the conclusion 
that antihypertensive treatment does not contribute to an additional fall of post-
prandial BP in the elderly Firstly, antihypertensive drugs with a central action on 
the sympathetic nervous system were not investigated in this study. Secondly, it 
might be that patients with orthostatic hypotension during antihypertensive 
medication, who were not included in this study, are more susceptible to post-
prandial BP reductions Thirdly, most of our hypertensive patients (with or 
without medication) had only mildly elevated BP. This may be of specific impor-
tance since we found that postprandial BP reduction is related to basal BP Final-
ly, the conclusion does not apply to antihypertensive drug treatment in very old 
people 
18 
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CHAPTER II 
Effects of nitrendipine and hydrochlorothiazide 
on postprandial blood pressure reduction 
and carbohydrate metabolism 
in hypertensive patients over 70 years of age 
Abstract 
Recently, it has been recognized that blood pressure (BP) in the elderly may 
decrease after a meal or oral glucose loading Calcium antagonists and diuretics 
have been advocated as first-line drugs for the treatment of hypertension in the 
elderly It is not known whether these antihypertensive drugs may further dete-
riorate or improve BP homeostasis after a meal Therefore, we studied in a dou-
ble-blind parallel study the effects of a 12 week treatment with nitrendipine, 20 
mg once daily, and hydrochlorothiazide, 50 mg once daily, on BP homeostasis 
after an oral glucose loading In iddition, the effects of both agents on carbohy 
drate metabolism were studied Before treatment, mean BP decreased by 13 ± 1 
mm Hg (SFM) (10%, p<0 001) 60 mm after the glucose loading in the nitrendi-
pine group ( n - 9 , age 73 ± 3 (SD) years) and by 9 ± 2 mm Hg (SLM) (7%, 
p<0 01) in the hydrochlorothiazide group (n = 13, age 76 ± 4 (SD) years) After 
12 weeks of treatment, oral glucose loading resulted in mean BP reductions of 7 ± 
2 mm Hg (6%, p<0 01) and 4 ± 2 mm Hg (4%, not significant) in the nitrendi 
pine and hydrochlorothiazide groups, respectively In the hydrochlorothiazide 
group, the area under the curve of plasma glucose was significantly higher after 
treatment than before (p = 0 03) We conclude that antihypertensive treatment 
with nitrendipine or hydrochlorothiazide improves BP homeostasis after an oral 
glucose loading In contrast to nitrendipine, 12 weeks of treatment with hydro 
chlorothiazide slightly impairs carbohydrate metabolism 
Introduction 
Recently, it has been recognized, that blood pressure (BP) in elderly subjects 
decreases after a meal [1,2] or oral glucose loading [3] The magnitude of this post-
prandial BP reduction is correlated to basal BP and age [1,2] We found that anti-
hypertensive treatment with diuretics, /3-blockers, vasodilators, or a combination 
of these drugs in the elderly did not cause a further decrease after a meal [4] The 
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present study was designed to investigate whether antihypertensive treatment 
actually may improve postprandial BP homeostasis in hypertensive elderly Since 
both calcium antagonists and diuretics have been advocated as first-line drugs in 
the treatment of hypertensive elderly, we studied the effects of a 12-week treat­
ment with the new long-acting calcium antagonist nitrendipine and the diuretic 
hydrochlorothiazide on postprandial BP reduction in patients over 70 years of 
age In addition, the effects of either therapy on carbohydrate metabolism were 
studied 
Patients and Methods 
In a double-blind, randomized, parallel-group clinical trial, the hemodynamic and 
metabolic effects of 12 weeks of treatment with nitrendipine 20 mg once daily 
given to 15 hypertensive elderly patients were compared to those with hydrochlo­
rothiazide 50 mg once daily given to 16 hypertensive elderly patients Before 
active treatment, patients received 4 weeks single-blind placebo therapy For the 
present, study 22 patients were randomly selected Because of technical failures, 
the oral glucose loading could not be performed in all patients Nine patients were 
treated with nitrendipine and 13 patients with hydrochlorothiazide All patients 
were 70 years or older and were enrolled in the study if they had, after a washout 
period of 10 weeks, a mean supine diastolic BP of 95 to 120 mm Hg or a mean 
systolic BP of 180 mm Hg or more, measured at three consecutive visits Patients 
with the following medical histories were excluded angina pectoris, congestive 
heart failure, myocardial infarction, cerebrovascular accident, diabetes mellitus, 
gout and/or a plasma creatinine concentration of 150 μιηοΐ/ΐ or more The clinical 
characteristics of the two groups are presented in Table 1 They did not differ in 
age, BP, heart rate and Quetelet index 
Table 1 Clinical characteristics of study subjects (mean SD) 
Age (years) mean 
range 
Sex (male/female) 
Quetelet index (kg/m2) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
I leart rate (beats/mm) 
Nitrendipine 
(n = 9) 
73 ± 3 
7 0 - 7 8 
4 / 5 
2 7 + 5 
187 ± 15 
106 ± 5 
78 ± 14 
Hydrochlorothia7id< 
( п = П ) 
76 ± 4 
7 0 - 8 4 
3 / 10 
27 ± 4 
187± 17 
102 ± 5 
69 ± 10 
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In each patient, an oral glucose loading test was performed before and at the end 
of the treatment period. Prior to these tests, the patients followed a diet rich in 
carbohydrates for 3 days. All studies were carried out in the morning after an 
overnight fast and 24 h after drug administration. At time 0 the subjects consumed 
75 g glucose in 300 ml water within 5 min. BP (Arteriosonde®) and heart rate 
(electrocardiogram) were measured in the supine position at regular intervals of 5 
min from —20 to 120 minutes. Thirty min before the start of the glucose loading a 
21-gauge butterfly was inserted in an antccubital vein and kept patent with phy­
siologic saline. At times 0, 30, 60, 90, and 120 min blood samples were collected 
for measurement of plasma glucose, insulin (radioimmuno-assay) and plasma 
catecholamines (radioenzymatic assay [5]). 
Statistical comparisons between paired observations were made with Student's t 
test when appropriate; otherwise Wilcoxon's signed rank test was used. The 
Mann-Whitney U test was used to compare the groups on quantitative data. In 
order to reduce the overall probability of a type 1 error, a level of significance of 
p<0.01 was employed (Bonferroni's correction). Comparison between curves 
was made with a distribution-free analysis of variance [6]. In this test, a ρ level of 
0.05 or less was considered to be significant. To study the independent effects of 
age and basal BP on BP responses, a multiple regression analysis was performed. 
Mean BP was calculated as the sum of diastolic BP and one third of pulse pressure. 
The area under the curve was calculated by applying the trapezoidal rule. All 
values given in tables and text are expressed as mean ± SEM, unless indicated 
otherwise. 
Results 
The response of BP, heart rate, and plasma norepinephrine to oral glucose loading 
before and during nitrendipine or hydrochlorothiazide treatment is presented in 
Table 2 and Fig 1. Both treatments caused a significant fall of BP after 12 weeks of 
treatment (p<0.01). The response of BP to either treatment was not significantly 
different. After oral glucose loading before treatment, mean BP decrease by 13 + 
1 mm Hg (10%, p<0.001, t 60 min) in the nitrendipine group and by 9 + 2 mm 
Hg (7%, p<0.01; t 60 min) in the hydrochlorothiazide group. After 12 weeks of 
treatment, oral glucose loading resulted in mean BP reductions of 7 + 2 mm Hg 
(6%, p<0.01; t 60 min) and 4 + 2 mm Hg (4%, not significant; t 60 min) in the 
nitrendipine and hydrochlorothiazide groups, respectively. After 12 weeks of 
treatment, the percentage mean BP changes at 60 min after the glucose loading 
were significantly lower in both groups when compared with pretreatment values 
(Fig 2). Comparison between the pre- and posttreatment curves of mean BP 
reductions revealed only in the nitrendipine group a significant difference 
(p=0.04). Multiple regression analysis for the total group (n=22) showed that the 
pretreatment change in mean BP at time 60 min was correlated to basal mean BP 
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Figure 1 Mean changes of mean blood pressure, heart rate and norepinephrine 
after oral glucose loading before and after treatment in both groups 
(r= -0.51, p = 0.02) and age (r= - 0 43, p = 0 05). In Fig 3, the pretreatment basal 
mean BP is plotted against the mean BP at 60 mm. The plot shows a significant 
deviation of the regression line in slope (p=0 02) and intercept (p = 0 04) from the 
line of identity, which means that the changes of BP are proportionally related to 
basal BP. 
In both treatment groups, heart rate did not change after 12 weeks of treatment. 
The influence of oral glucose loading on heart rate was not significantly influen­
ced by treatment in either group (Fig 1) Only in the hydrochlorothia7ide group 
heart rate increased significantly after oral glucose loading before and after treat­
ment. In the nitrendipine group, no change in heart rate could be demonstrated 
However, comparison between treatment groups revealed no differences in heart 
rate responses after glucose loading. 
Baseline plasma norepinephrine levels were slightly, but insignificantly, lower 
after treatment in both groups. In the nitrendipine group basal plasma norepi­
nephrine decreased from 2 01 ± 0 40 to 1.77 ± 0.22 nmol/l In the hydrochloro-
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Table 2 Effects of oral glucose loading on systolic and diastolic blood pressure 
before and after 12 weeks of treatment 
Systolic BP 
(mm Hg) 
Diastolic BP 
(mm Hg) 
Time 
(mm) 
0 
30 
60 
90 
120 
0 
30 
60 
90 
120 
Nitrendipine 
Before 
174 ± 4 
163 ± 5 ^ 
150 ± 5 ' ' 
165 ± 5 
168 ± 5 
106 + 2 
96 ± 3 ' 
94 ± 2 
99 ± 3 
99 + 3 
After 
161 ± 4" 
157 ± 4 
154 ± 5 
157 ± 5 
158 ± 6 
99 ±3* 
9 1 + 4 
92 ± 4 
93 ± 4 -
94 ± 4 " 
I lydrochlorothiazide 
Before 
175 ± 6 
169 ± 6 
166 ± 5 
167 ± 5 
169 + 5 
98 ± 1 
89 ± 2 
89 ± 2 -
91 ± 3 
92 ± 2 ' 
After 
157 ± 7 ^ 
155 ± 6 
155 ± 5 
156 ± 6 
155 ± 5 
89 ± 2SS 
84 ± 2 ' 
84 + 2" 
85 ± 2 
85 ± 2 
p<0 01 and " p<0 001 compared with baseline values 
§ p<0 05, §§ p^0 01 and §§§ p ¿ 0 001 compared with prctreatment baseline values 
Δ M A P % nitrendipine hydrochlorothiazide 
0 -
1 0 -
- 2 0 -
X 
before alter 
p . 0 04 
before after 
p . 0 0 5 
Figure 2 Individual percentage changes of mean blood pressure 60 mm after oral 
glucose loading before and after treatment in both groups. 
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Figure 3 Pretreatment basal mean blood pressure versus pretreatment mean 
blood pressure 60 mm after oral glucose for the total group (n=22) 
AUC ρ = 003 
о pretreatment 
• post treat ment 
AUC ρ N5 
60 120 
Mm 
Figure 4 Effects of oral glucose loading on plasma glucose and insulin before and 
during treatment. AUC means area under the curve. NS means not significant. 
The ρ values refer to the significance of the difference between pre- and posttreat-
ment A UC values. 
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thiazide group basal plasma norepinephrine decreased from 2.00 ± 0.32 nmol/1 
before treatment to 1.69 ± 0.14 nmol/1 after treatment. Before treatment, oral glu-
cose loading resulted in a slight and insignificant increase of plasma norepineph-
rine in both groups. After treatment, norepinephrine increased significantly in 
response to oral glucose loading in the hydrochlorothiazide group, but not in the 
nitrendipine group. However, comparison of plasma norepinephrine responses 
did not yield any difference between pre- and posttreatment values within or 
between both groups. 
In Fig 4, the curves of glucose and insulin are depicted after glucose loading in 
each group. Treatment with hydrochlorothiazide resulted in a slight increase of 
baseline glucose (0.3 ± 0.1 mmol/l, p=0.06) and insulin (4 ± 1 mU/1, p<0.05), 
whereas treatment with nitrendipine did not change these parameters. The area 
under the curve of plasma glucose after oral glucose loading was similar before 
and after treatment with nitrendipine. In the hydrochlorothiazide group, the area 
under the curve of plasma glucose was significantly higher after treatment than 
before (p=0.03). The area under the curves of insulin did not change significantly 
in either group. 
Discussion 
A decrease of BP after a meal or oral glucose loading has been described before 
[1,3]. Postprandial BP reduction is an age and BP related phenomenon [1,2]. 
Elderly hypertensives are the most likely to have postprandial decreases in BP. BP 
also decreases after an oral glucose loading in elderly persons, dependent on age 
and basal BP, and comparable in magnitude and time course to the BP reduction 
after a meal [3,4]. We reported earlier that different types of antihypertensive 
drugs did not cause a further BP reduction after a meal [4], contrary to what one 
might have expected based on the well-known interference of these drugs with BP 
homeostasis in the elderly. Moreover, in the present study we found that after 12 
weeks of treatment with nitrendipine or hydrochlorothiazide, the decrease of BP 
after an oral glucose loading was significantly lower than before treatment, in 
accordance with our finding in the untreated patients, in whom the mean BP, 60 
min after the glucose administration, was proportionally related to the basal mean 
BP. 
The mechanism of postprandial BP reduction is not known, but based on pre-
vious studies [3], we suggest that oral glucose loading induces a specific vasodila-
tion of splanchnic vasculature that is, in hypertensive elderly patients, incomple-
tely counterbalanced by activation of the sympathetic nervous system, due to an 
age and BP related decrease of baroreflex sensitivity [7,8]. A decrease of baroreflex 
sensitivity in this study is suggested by absent or small changes in heart rate and 
plasma norepinephrine, in the face of marked BP reductions induced by glucose 
loading. The fact that not only the absolute but also the percentage fall of BP was 
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reduced by either antihypertensive treatment might indicate that these treatments 
cause an improvement of BP homeostatic mechanism Indeed, M e l cay et al found 
after chronic nifedipine therapy not only a resetting of the sinoaortic baroreflex 
but also an increase in its sensitivity, as was established by the response of heart 
rate and BP to phenylephrine [9] However, several other studies with nifedipine 
[10J and nicardipine [11] showed a resetting of baroreflexes without any change in 
sensitivity In our study, an increase of baroreflex sensitivity after treatment can 
be derived from the finding that oral glucose loading elicited, despite lower BP 
reductions than before treatment, heart rate and norepinephrine responses com­
parable to those before treatment 
In this study, we used an oral glucose loading test instead of a meal in order to 
determine postprandial BP reduction Therefore, we had the opportunity to study 
at the same time the effects of both treatments on carbohydrate metabolism in the 
elderly Calcium antagonists may interfere with the second phase of insulin secre­
tion, which depends on a C a 2 + influx through the calcium channel [12] Studies of 
isolated pancreatic islets of Langerhans have shown that nitrendipine and several 
other types of calcium antagonists cause a dose dependent inhibition of insulin 
output [13] However, in the present study of nondiabetic elderly hypertensives, 
no evidence for an influence of nitrendipine on glucose tolerance was found Also, 
other studies did not found any effect of nitrendipine on plasma glucose or insulin 
response to oral glucose loading [12,14] In contrast, hydrochlorothiazide treat­
ment caused the well-known impairment of carbohydrate metabolism 
In conclusion, our data indicate that antihypertensive treatment with nitrendipine 
or hydrochlorothia7ide in hypertensive patients over 70 years of age improves BP 
homeostasis after an oral glucose loading In contrast to nitrendipine, 12 weeks of 
treatment with hydrochlorothiazide slightly impairs carbohydrate metabolism 
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CHAPTER III 
Blood pressure reduction after oral glucose 
loading and its relation to age, blood pressure 
and insulin 
Abstract 
Recently it has been demonstrated that blood pressure (BP) in the elderly may 
decrease after a meal. The pathophysiologic mechanism of this phenomenon is 
unknown. It has been suggested that a failure of insulin-mediated sympathetic 
nervous system activation plays a role. To evaluate the role of endogenous insulin, 
the effects of oral glucose and oral fructose loading on BP, heart rate and norepi-
nephrine levels were studied in 10 young normotensive volunteers (YN), 10 
young hypertensive patients (YH), 10 elderly normotensive volunteers (EN) and 
10 elderly hypertensive patients (EH). I'ructose, 75 g/300ml of water, elicited-in 
contrast to the same amount of glucose - only a small increase in insulin and glu-
cose levels. After glucose loading, mean arterial BP decreased by 17 mm Hg in the 
EH group (p<0.001), 6 mm Hg in the EN group (p<0.01), and 7 mm Hg in the 
YH group (p<0.001), and did not change in the YN group. After oral fructose 
loading, BP did not change in any group. In all groups except the YN group, the 
increases of norepinephrine level and heart rate after both tests were not signifi-
cantly different. These findings suggest that the BP reduction after glucose loa-
ding is related to glucose-mediated factors. A failure of insulin-mediated sympa-
thetic nervous system activation docs not appear to play a major role. 
Introduction 
Blood pressure (BP) in the elderly has been shown to decrease after a meal. This 
was found both in frail, institutionalized elderly patients [1] as well as in healthy, 
community-dwelling elderly persons [2,3]. The clinical significance of this pheno-
menon is not clear, but in a recent study Lipsitz et al identified 8 elderly patients 
with meal-related syncope [4]. The mechanism of postprandial BP reduction is 
unknown. It has been suggested that failure of insulin-mediated sympathetic ner-
vous system activation causes the decrease of BP after a meal [1]. Indeed, sympa-
thetic nervous system activation by intravenous administration of insulin and glu-
cose has been shown to be blunted in the elderly [5] but not in younger persons 
[6]. However, oral glucose loading induces a greater sympathetic nervous system 
activation in elderly than in younger persons [7]. To elucidate the role of insulin in 
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the phenomenon of postprandial BP reduction, we studied the effects of oral glu­
cose loading on the cardiovascular and sympathetic nervous systems in healthy 
volunteers and in patients of different ages and BP levels. 
Methods 
Pourty normotensive and hypertensive persons of several age groups participated 
in this study. The first group consisted of 10 healthy young volunteers with a nor­
mal blood pressure (YN). For the second group, 10 young hypertensive patients 
(YH) were randomly selected from the outpatient clinic. Hypertension was defi­
ned as a supine systolic BP >160 mm Hg and/or a supine diastolic BP >95 mm 
Hg, measured on 3 occasions using a standard sphygmomanometer. The third 
group consisted of 10 healthy, community-dwelling, normotensive elderly volun­
teers older than 70 years (EN). For the fourth group 10 hypertensive patients 
older than 70 years were randomly selected from the outpatient department (EH). 
No participant had a history of myocardial infarction, cerebrovascular accident or 
diabetes mellitus. All patients had uncomplicated essential hypertension and had 
not taken antihypertensive medication for at least 1 month before the study. Cha­
racteristics of the 4 groups are presented in Table 1. 
Table 1 Characteristics of study subjects (mean ± standard error of the mean). 
Sex (men/women) 
Age (years) mean 
range 
Quetelet index (kg/m2) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Heart Rate (beats/min) 
YN 
(n = 10) 
6/ 4 
28± 1 
23-32 
21± 1 
I07± 2 
72± 3 
62± 2 
YH 
(n = 10) 
6/ 4 
44± 2 
30-51 
25± 1 
146± 6 
101+ 4 l 
74± 3 
F N 
(n = 10) 
4/ 6 
75± 2 
70-87 
25± 1 
1S2± 2 
81± 2 
6 2 1 2 
EH 
(n = 10) 
4/ 6 
75± 1 
71-84 
27± 1 
191+ 4 
105± 2 ' 
71± 4 
ρ S 0 05 versus young normotensives 
ρ < 0.05 versus elderly normotensives 
In each subject an oral glucose- and an oral fructose loading test was performed in 
a random, single-blind order with an interval of 1 week. Before these tests, the 
participants followed a diet rich in carbohydrates for 3 days. All studies were car­
ried out in the morning after an overnight fast. At time 0 the subjects consumed 75 
g of glucose or fructose in 300 ml of water within 5 min. BP (Arteriosonde®) and 
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heart rate (electrocardiogram) were measured in the supine position at regular 
intervals of 5 min from —20 to 120 min. A 21 gauge butterfly needle was inserted 
at time —30 min in an antecubital vein and kept patent with physiologic saline 
solution. At time 0, 30,60, 90 and 120 min, blood samples were collected for mea-
surement of glucose, insulin (radioimmuno assay) and norepinephrine levels (ra-
dioenzymatic assay [8]). 
Statistical comparisons between paired observations were made with a Student t 
test when appropriate; otherwise Wilcoxon's rank sum test was used. To reduce 
the overall probability of a type I error, a level of significance of p<0.01 was used 
(Bonferroni's correction). Comparison between curves were made with a distri-
bution-free analysis of variance [9]. In this test a p-value of <0.05 was considered 
to be statistically significant. To study the independent effects of age, Quetelet 
index, basal BP, insulin and glucose on BP responses, a multiple regression analy-
sis was used. Mean arterial pressure was calculated as the sum of diastolic BP and 
one-third of pulse pressure. All values given in tables and text are expressed as 
mean ± standard error of the mean. 
Results 
Tables 2 and 3 present the mean values of mean arterial BP, heart rate, norepi-
nephrine, glucose and insulin in the 4 study groups, both after glucose and after 
fructose loading. In Fig 1 and 2 the changes of these measurements in each test are 
shown. 
Blood pressure 
BP, expressed as mean arterial pressure, decreased significantly in response to glu-
cose loading in YH, EN and EH (Table 2 and 3). After fructose loading, BP 
remained essentially unchanged in all 4 groups. 
Systolic BP decreased by 5 ± 1 mm Hg (from 146 ± 6 to 141 ± 5 mm Hg, p<0.01) 
in the YH group, by 5 ± 3 mm Hg (from 144 ± 6 to 139 ± 7 mm Hg, not signifi-
cant) in the EN group and by 23 ± 4 mm Hg (from 188 ± 5 to 165 ± 6 mm Hg, 
p<0.001) in the EH group. Diastolic BP decreased by 7 ± 2 mm Hg (from 101 ± 
4 to 94 ± 5 mm Hg, p<0.01) in the YH group, by 6 ± 1 mm Hg (from 81 ± 2 tot 
75 ± 3 mm Hg, p<0.001) in the EN group and by 14 ± 2 mm Hg (from 104 ± 3 
to 90 ± 3 mm Hg, p<0.001) in the EH group. 
The decrease of mean arterial BP after glucose loading was significantly greater in 
the EH group than in the EN aijd YH groups (Fig 1). BP decreased in every 
elderly subject (Fig 3). The maximal decrease in BP was in an 84-years-old hyper-
tensive woman who had a 30 mm Hg decrease in mean arterial BP. In no patient 
did the BP decrease cause subjective symptoms. Regression analysis revealed a 
dependence on age (p=0.07) and basal systolic BP (p=0.05). Quetelet index, basal 
diastolic BP and insulin and glucose levels were not significantly correlated with 
mean arterial BP reduction. 
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Table 2 Mean values (± standard error of the mean) of mean arterial blood pres­
sure (MAP), heart rate (HR), norepinephrine (NE), glucose and insulin before and 
after oral fructose (F) or glucose (G) loading in both young groups. 
MAP 
(mm Hg) 
time 
(mm) 
0 
30 
60 
90 
120 
normotcnsivc 
G 
85±2 
83±1 
84±1 
85±2 
87+2 
F 
85±2 
87±2 
86±2 
87±2 
87±2 
hypertensive 
G 
116±4 
110±5-' 
l l l ± 5 
114±5 
116±5 
F 
115±5 
115±4 
114±3 
114±5 
115±4 
p=0 09 p=0.03 
HR 
(beats/ 
minute) 
0 
30 
60 
90 
120 
62±2 
64+2 
63±3 
6 5 ± 3 
64+2 
62±3 
61±3 
66±3 
6 7 ± 3 ' 
68±3 
74±3 
80±3 
79±3 
77±3 
77±3 
74±2 
7 1 ± 2 ' 
76±3 
75±2 
77±2 
p=0.55 =0.06 
NF. 
(nmol/l) 
0 
30 
60 
120 
0.77±0.10 
1.08±0.15 
1.01±0.14 
LOStO-lO' 
0 76±0 08 
0.92 ±0.09 -
0.89±0.09' 
0.83 ±0.09 
1.39+0.18 
1.91 ± 0 22* 
1.80±0.19~ 
1.50±0.13 
1.28±0.18 
1.60±0.19 
1.56±0.21 
1.53±0.17 
p=0.02 p=0.09 
Glucose 
(mmol/l) 
0 
30 
60 
90 
120 
4.1+0.2 
6 .9±0.4 · · 
6 .4±0.5 : 
5.1±0.3 
4.2±0.3 
4.2±0.1 
4.7±0.2 : 
4.6±0.2 
4.2+0.2 
4.1±0.2 
4.610.2 
7.9±0A" · 
9 . 0 ± 0 . 8 " 
8.1±0.8 
6.7±0.5· 
4.5±0.1 
5.0±0.1 
5.2±0.3 
5.0±0.2 
4.7±0.1 
p=0.0027 p=0.0004 
Insulin 
(mU/l) 
- p<0.01 
·-' p<0.001 
0 
30 
60 
90 
120 
6 ± 1 
68117^ 
55+12^ 
38+ 7· 
19+ 5 
P= 
5 ± 1 
12±2-
1 3 ± l s 
9 ± 1 
8 ± 1 
=0.0003 
8± 1 
44± б " 
57± 6 -
61 ± 9· 
54±10··· 
P= 
7 ± 1 
1 3 ± Γ 
16±1 ; 
19±r 
1 2 ± Γ 
=0.0004 
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Table 3 Mean values (± standard error of the mean) of mean arterial blood pres­
sure (MAP), heart rate (HR), norepinephrine (NE), glucose and insulin before and 
after oral fructose (F) or glucose (G) loading in both elderly groups 
MAP 
(mm Hg) 
time 
(mm) 
0 
30 
60 
90 
120 
normotensive 
G 
102±3 
96 + 3 
96±4 
100±4 
101+4 
b 
101±3 
106 ± 4 
104±4 
10715 
106 + 5 
hypertensive 
G 
132±2 
117±3 
115±3 
120±3 
122±3 
F 
130+3 
131±3 
128±3 
127±3 
130+4 
p = 0 006 p=0 0001 
HR 
(beats/ 
minute) 
0 
30 
60 
90 
120 
62±2 
67±2 " 
66±2 J 
67±2 
65±2 
63±2 
65±2 
66±2 
68 + 2-
69±2 
71 ±4 
75±4 
74±3 
72 ±4 
75±3 
73 ±3 
73±3 
75±5 
76±4 
78±5 
p=0 19 =0 78 
N E 
(nmol/1) 
0 
30 
60 
120 
1 72±0 18 
2 23±0 10" 
2 2 1 ± 0 17'· 
2 08±0 22 
1 81±0 21 
2 08±0 21 
2 26±0 26 
2 19±0 31 
2 2810 32 
2 79+0 34 
2 6410 30 
2 4610 21 
2 5 1 + 0 3 1 
2 59+0 32 
2 86+0 38 
2 58+0 32 
p=0 44 p=0 13 
Glucose 
(mmol/1) 
0 
30 
60 
90 
120 
4 8+0 1 
7 9 1 0 5 
9 5 1 0 6 
9 2 + 0 6 ι 
8 3 1 0 6 
4 9 + 0 2 
5 6 + 0 2 
6 1 + 0 4 
5 7+0 3 
5 3 1 0 2 
5 0 + 0 3 
8 3 1 0 6 
10 2 1 0 7 
9 8+0 8 
9 3 1 1 1 ' 
4 9+0 3 
5 7+0 3 
6 2 1 0 4 
6 1 + 0 4 
6 0 + 0 5 
p=0 0002 p=0 0005 
Insulin 
(mU/l) 
pSOOl 
p < 0 001 
0 
30 
60 
90 
120 
8+1 
39+5 
58+9 
5718 ' 
50+7 
p = 0 0002 
9 + 2 
20+1 ' 
2112 
19+2 
15+2 
11+ 2 
51+ 7 
8 3 Í 1 6 1 
92+18 
80114 
= 0 0002 
11+2 
2114 
2515 
2415 
2114 
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oral glucose loading oral fructose loading 
ДМАР(глтНд ) 
-20 J , , 1 1 τ -> r 
AHR(bpm) 
-5 ~H 1 1 1 1 —ι 1 1 1 Η 
0 60 120 0 60 120 
Time (min) 
Figure 1 Mean changes of mean arterial pressure (MAP) and heart rate (HR) 
after oral glucose- (left) and oral fructose loading (right) in young normotensive 
(YN, open triangles) young hypertensive (YH, solid triangles), normotensive 
elderly (EN, circles) and hypertensive elderly subjects (EH, dots). 
Curve analysis revealed significant differences for MAP after glucose between EH 
and EN (p<0.001) and between EH and YH (p<0.001), and for HR after glucose 
between EN and YN (p<0.05). 
Heart rate 
The influence of glucose and fructose on heart rate was not significantly different 
in any group (Table 2 and 3). After both tests a slight increase in heart rate was 
observed. Remarkably, in view of the corresponding decrease in BP, a significant 
increase of heart rate after glucose loading occurred in the EN group, whereas no 
increase occurred in the EH group. 
Norepinephrine 
Basal plasma norepinephrine levels before the glucose and fructose tests were sig-
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nificantly higher in the EN than in the YN group. In addition, basal plasma nor-
epinephrine levels were significantly higher in the EH than in YH group. Glu-
cose loading resulted in a significant increase in norepinephrine level, lasting for 
120 min in the YN group, 60 min in the YH and EN groups and 30 min in the EH 
group. Fructose loading resulted in significant increases in norepinephrine levels 
in the normotensive but not in the hypertensive groups. 
The effects of glucose and fructose on plasma norepinephrine level were not signi-
ficantly different in any of the groups except in the YN group, which had signifi-
oral glucose loading oral fructose loading 
ÛGlucose(mmol/l I 
Δ lnsulin{mE/1 ) 
Δ NE Inmol/I I 
0 60-1 
Figure 2 Mean changes of glucose, insulin and norepinephrine (NE) after oral 
glucose- (left) and oral fructose loading (right) in young normotensive (YN, open 
triangles), young hypertensive (YH, solid triangles), normotensive elderly (EN, 
circles) and hypertensive elderly subjects (EH, dots). 
Curve analysis revealed significant differences for glucose after oral glucose 
between EN and YN (p-<0.01) and for glucose after fructose between EH and YH 
(p<0.01) and between EN and YN (p<0.05). Insulin and NE after fructose were 
significantly different between EN and YN (p<0.05 andp<0.05, respectively). 
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cantly higher norepinephrine levels after glucose than after fructose loading. 
Comparison of the curves of plasma norepinephrine responses after glucose did 
not yield any statistical significantly difference between the study groups (Fig 2). 
Glucose and insulin 
Oral fructose loading resulted in a slight but significant increase of plasma glucose 
and insulin not exceeding, however, an increase of plasma levels of > 1.3 mmol/l 
and 15 mU/1, respectively, in any of the groups (Fig 2). Maximum insulin respon-
ses were 62 mU/1 at time 30 min in the YN group, 53 mU/1 at time 90 min in the 
YH group, 50 mU/1 at time 60 min in the EN group and 81 mU/1 at time 90 min 
in the EH group. Comparison of the curves and area under the curves of insulin 
responses did not yield a significant difference between groups (Fig 2). The 
increase of plasma glucose after oral glucose loading was similar in the YH, EN 
and EH groups. In the YN group, however, the curve and the area under the 
curve of the increases of plasma glucose were significantly lower than in the EN 
group (Fig 2). 
oral glucose loading 
M A P l m m H g 
HO -
120 -
100 
60 
Time (mm ) 
Figure 3 Individual changes in mean arterial pressure (MAP) after oral glucose 
loading in normotensive and hypertensive elderly persons. 
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Discussion 
This study shows that BP decreases markedly after oral glucose loading in unse-
lected elderly hypertensive patients without overt cardiovascular disease or dia-
betes mellitus and not taking antihypertensive medications. In addition, a slight 
but significant decrease in BP also was observed in healthy elderly normotensive 
and in young hypertensive subjects. In young normotensive subjects, however, 
BP did not change during this test. These findings indicate that the decrease in BP 
after oral glucose loading is an age- and BP-related phenomenon. In contrast, we 
did not observe an effect on BP in any of the study groups after oral ingestion of a 
fructose solution. Since fructose loading, contrary to isocaloric and isovolumic 
glucose loading, elicited only a small increase in plasma glucose and insulin levels, 
we suggest that glucose- and insulin-related factors play a specific role in the 
pathophysiology of the observed BP reductions. 
The influence of oral glucose loading on BP in elderly subjects has not been stu-
died extensively. Young et al [7] found no change in mean arterial pressure after 
administration of a 100 g of glucose solution to 12 elderly normotensive persons 
(mean age 72.9 ±1 .9 years). Robinson et al studied BP responses to glucose (50 g) 
ingestion in 5 orthostatic elderly and 5 elderly control subjects and found a mar-
ked decrease in BP in patients with orthostatic hypotension but not in control 
subjects [10]. 
An important role for carbohydrates and insulin in the postprandial BP reduction 
in elderly persons was first proposed by Lipsitz et al [1]. Based on earlier studies 
in their laboratory, they suggested that an age-related decrease of insulin-induced 
sympathetic nervous system activation may, at least in part, be responsible for 
postprandial hypotension. Failure of sympathetic nervous system activation was 
suggested to be mediated by blunting of baroreflex sensitivity by insulin or gluco-
se, as was found in some studies [11,12]. We found that BP decrements were most 
pronounced in hypertensive elderly persons. Since baroreflex sensitivity decreases 
with BP and age [13,14,15], the substantial decrease in BP after glucose but not 
after fructose loading appears to support to their theory. However, the increases 
of plasma norepinephrine level and heart rate, both as a measure of sympathetic 
nervous system activation, were not significantly different after either type of test. 
BP in the group of elderly hypertensive patients decreased after glucose but not 
after fructose, in the face of a comparable activation of the sympathetic nervous 
system. Therefore, we suggest that insulin-mediated impairment of sympathetic 
nervous system activation does not play a major role in the decrease in BP after 
glucose. 
Oral glucose and fructose loading may exert disparate effects on regional and sys-
temic blood flow. Qamar et al [16], using a transcutaneous Doppler ultrasound 
method, found in healthy volunteers an increase of superior mesenteric blood 
flow of 53% at the end of the ingestion of an isotonic glucose solution. No signifi-
cant change in blood flow was found after ingestion of a lactulose solution. 
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However, unlike fructose, very small amounts of lactulose are absorbed in normal 
subjects. Da Costa et al [17] studied patients with idiopathic autonomic failure 
and found a far greater decrease in BP after glucose than after xylose ingestion. 
Since in these patients neurocirculatory reflexes were absent, the findings suggest 
that the sugars had different effects on splanchnic blood pooling. Based on these 
studies we suggest that oral glucose loading induces a specific vasodilation of 
(splanchnic) vasculature, which, in elderly and hypertensive persons, is incomple-
tely counterbalanced by activation of the sympathetic nervous system, due to an 
age- and BP related decrease of baroreflex sensitivity. Indeed, the maximal per-
cent increases of norepinephrine levels after glucose loading in YN, YH, EN and 
EH were 40%, 37%, 30% and 22%, respectively. In addition, plasma levels of 
norepinephrine remained significantly elevated for 120, 90, 60 and 30 min, respec-
tively. 
Splanchnic or systemic vasodilation after glucose ingestion can be considered to 
be mediated by gut hormones. A possible role for vasoactive gastrointestinal pep-
tides was recently suggested by Hoeldtke et al [18], who found that postprandial 
BP reductions in patients with autonomic neuropathy can effectively be abolished 
by subcutaneous administration of the somatostatin analogue SMS 201-995. 
However, attempts to identify such a hormone have been unsuccessful. 
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CHAPTER IV 
Oral versus intravenous glucose loading 
and its relation to postprandial 
blood pressure reduction in the elderly 
Abstract 
Blood pressure (BP) in the elderly may decrease after a meal or after oral glucose 
loading. A role for insulin in this hypotensive effect is suggested by our earlier fin-
ding that BP in elderly subjects remained unchanged after oral fructose loading. 
To determine whether the hypotensive effects of glucose loading is specifically 
mediated by gastrointestinal factors or vasodilator properties of insulin, we stu-
died the effects of oral and intravenous glucose loading on BP, heart rate and 
plasma norepinephrine in normotensive and hypertensive elderly volunteers over 
70 years of age. After oral glucose mean arterial BP fell by 16 ± 2 mm Hg 
(p<0.001) in hypertensive elderly and by 8 ±1 mm Hg (p<0.001) in normoten-
sive elderly subjects. In contrast, we did not observe any effect of intravenous glu-
cose loading on BP in either of the elderly groups. These data indicate that it is 
unlikely that a vasodilator effect of insulin plays an important role in the fall in BP 
after oral glucose. Therefore, we suggest that interference of insulin with a by age 
or disease diminished sympathetic response to the by oral glucose induced 
splanchnic vasodilation, may be responsible for the fall in BP in the elderly. 
Introduction 
Up to now there have been several studies which have shown that blood pressure 
(BP) may fall after a meal in the elderly and in patients with autonomic failure 
[1,2,3]. Although the clinical significance remains uncertain, Lipsitz et al have 
described eight institutionalized elderly patients with meal-related syncope and 
large postprandial BP declines [4]. In a recent study we found a similar reduction 
of BP in the elderly after an oral glucose loading [5]. Oral fructose loading, howe-
ver, had no effect on BP in the elderly [5]. In addition, in patients with autonomic 
failure, there was a marked and prolonged fall in BP after oral glucose with only a 
small fall after oral xylose [6]. 
The mechanism of postprandial BP reduction is unknown, but is has been sugges-
ted that oral glucose induces a specific vasodilation of splanchnic vasculature, pos-
sibly mediated by stimulation of vasoactive gastrointestinal hormones or insulin, 
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which is incompletely counterbalanced by activation of the sympathetic nervous 
system [1,5]. Indeed, pretreatment with a somatostatin analogue octreotide (SMS 
201-995), which inhibited the secretion of almost all gastrointestinal hormones 
[7], completely prevents the fall of BP after oral glucose [8]. On the other hand, 
octreotide may exert its beneficial effect by suppression of insulin secretion. 
These findings indicate that insulin might play an important role in the phenome-
non of postprandial hypotension. Indeed, intravenous insulin has been reported 
to cause a decrease of BP and even hypotension and syncope in diabetic patients 
[9,10] and in patients with autonomic failure [11]. We therefore investigated the 
effects of oral glucose and intravenous glucose loading in healthy elderly volun-
teers. As postprandial BP reduction is related to baseline BP [1,5], both normo-
tensive and hypertensive elderly persons were studied. 
Methods 
Ten hypertensive and 10 normotensive subjects, aged 70 years or older, were 
recruited by a newspaper announcement. Hypertension was defined as a supine 
systolic BP >:160 mm Hg or a supine diastolic BP S95 mm Hg, measured after 20 
min of rest using a standard sphygmomanometer. Antihypertensive drugs were 
withdrawn for at least one month before the study. All subjects were without a 
history of myocardial infarction, cerebrovascular accident, congestive heart fai-
lure or diabetes mellitus. The study was approved by the local ethical committee. 
The clinical characteristics of both groups are listed in Table 1. The two groups 
did not differ in age, Quetelet index or heart rate, only in BP. 
Both oral glucose and intravenous glucose loading were performed in each subject 
with an interval of one week. All studies were carried out in the morning after an 
Table 1 Clinical characteristics of subjects (mean ± SD) 
Age (years) mean 
range 
Sex (men/women) 
Quetelet's-mdex (Kg/m2) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Heart rate (beats/mm) 
Normotensivcs 
(n=10) 
75± 4 
7 1 - 8 3 
5 / 5 
24± 3 
149±13 
81± 7 
62 + 10 
Hypertensives 
(n=10) 
74±5 
70-84 
4 / 6 
26± 3 
189±17 
102± 5 : 
70±14 
p<0.001 when compared with normotensive subjects 
BP = blood pressure 
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overnight fast. At time 0 min the subjects received 75 gram glucose in 300 ml of 
water orally or 40 gram glucose 40% solution/1.73 m2 body surface area intrave­
nously. BP was measured in the supine position using an Arteriosonde® and heart 
rate was calculated from an ECG-recording. BP and heart rate were measured at 
regular intervals of 5 min from —20 to 120 min. Five BP— and heart rate measure­
ments, taken from time —20 to 0 min, were averaged and considered as the base­
line BP and heart rate and further denoted as time 0 min. As the subjects consu­
med the glucose solution within 5 min, no measurement of BP and heart rate was 
performed at time 5 min after oral glucose. The glucose solution, which was given 
intravenously, was injected within 2 minutes. A 21 gauge butterfly needle was 
inserted 30 min before the start of the test in an antecubital vein and kept patent 
with physiologic saline. At timeO, 15, 30, 60 and 120 min blood samples were col­
lected for measurement of glucose, insulin and plasma catecholamines [12]. 
Statistical comparisons between paired and unpaired observations were made 
with Student t test when appropriate; otherwise Wilcoxon's signed rank and ran­
ked sum tests were used. To reduce the overall probability of a type I error, a level 
of significance of ρ <0.01 (two-sided) was employed. Comparisons between cur­
ves were made with a distributionfree analysis of variance [13]. In this test a p-
level of 0.05 or less was considered to be statistically significant. Mean arterial 
pressure (MAP) was calculated as the sum of diastolic BP and one third of pulse 
pressure. All values given in tables and text are expressed as mean ± scm, unless 
indicated otherwise. 
Results 
In Table 2 all baseline hemodynamic and biochemical data of both groups are lis­
ted. Fig 1 and 2 present the course of BP and heart rate after oral and intravenous 
glucose loading in the normotensive and hypertensive groups. 
Table 2 Baseline values in both groups (mean ± sem). 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Heart rate (bpm) 
Glucose (mmol/1) 
Insulin (mU/1) 
Norepinephrine (nmol/1) 
Epinephrine (nmol/1) 
BP = blood pressure. 
Normoiensives 
oral 
137 ± 4 
79 ± 2 
62 ± 3 
4.9 ± 0.2 
9 ± 1 
1.78 ± 0 . 2 8 
0.16 + 0.03 
intravenous 
135 ± 5 
78 ± 2 
65 ± 2 
5.0 ± 0.2 
9 ± 1 
1.64 ± 0 . 1 3 
0.19 ± 0 . 0 3 
Hypertensives 
oral 
175 ± 5 
101 ± 2 
70 + 5 
4.9 ± 0.3 
9 ± 1 
1.66 ± 0 . 1 5 
0.19 ± 0.03 
intravenous 
166 ± 5 
96 ± 2 
68 ± 4 
4.7 + 0.2 
10 ± 1 
1.99 ±0.25 
0.20 ± 0.05 
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After oral glucose systolic BP decreased in the normotensive subjects with a maxi­
mum of 6 ± 3 mm Hg (5%, p=0.01) and diastolic BP fell by 8 ± 1 mmHg (11%, 
p<0.001). MAP decreased from 98 ± 3 to 91 ± 3 mm Hg (8%, p<0.001). In the 
hypertensive subjects systolic BP decreased significantly within 30 min reaching a 
maximum of 19 ± 4 mm Hg ( l l%,p<0.01) at time 60 min. A similar pattern was 
found for the course of diastolic BP with a maximum decrease of 16 ± 2 mm Hg 
(15%, p<0.001). MAP fell from 125 ± 2 to 109 ± 3 mm Hg (13%, p<0.001). The 
decrease of MAP after oral glucose was significantly greater in the hypertensive 
group than in the normotensive group (curve analysis p=0.02). Five min after the 
start of the intravenous glucose injection, systolic BP decreased by 15 ± 3 mm Hg 
(11%, p<0.01) in the normotensive group and by 13 ± 4 mm Hg(8%, p<0.01) in 
Δ Systol ic blood pressure —. 
(mmHg ) 
Δ Diastolic blood pressure 
(mmHg) 
1 0
Ί 
ЛНеаП rate (beats/min) 
0 30 60 90 120 
Time (min) 
Figure 1 Mean values of blood pressure and heart rate after oral (circles) and 
intravenous (dots) glucose loading in normotensive elderly subjects. * denotes 
p<0.01 and '•'* p<0.001 when compared with baseline values. The p-values given 
in the figure represent curve analysis between both types of test. 
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Δ Systolic blood pressure 
(mmHg) 
Figure 2 Mean values of blood pressure and heart rate after oral (circles) and 
intravenous (dots) glucose loading in the hypertensive elderly subjects. "· denotes 
p<0.01 and "''• p-<0.001 when compared with baseline values. The p-values given 
in the figure represent curve analysis between both types of test. 
the hypertensive subjects. Diastolic BP fell only in the normotensive group by 9 
± 3 mm Hg (11%, p<0.01). Within 10 min after the start of injection systolic and 
diastolic BP had returned to baseline values and remained essentially unchanged 
in both groups. The ρ values for the comparison of the curves obtained with oral 
and intravenous glucose loading arc given in Fig 1 and 2. 
In the normotensive group, the heart rate increased from 62 ± 3 to 68 ± 3 beats/ 
min (11%, p<0.01) at time 30 min after oral glucose and decreased from 65 ± 2 to 
59 ± 3 beats/min (9%, p<0.01) at time 60 min after intravenous glucose loading 
(Fig 1). This difference in the heart rate response after both tests in the normoten-
sives was highly significant (p<0.001). The influence of oral and intravenous glu­
cose loading on the heart rate was not significantly different in the hypertensive 
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Δ Norepinephrine 
(nmol/l) 
Figure 3 Mean values of plasma norepinephrine and plasma epinephrine after 
oral (circles) and intravenous (dots) glucose loading in normotensive and hyperten­
sive elderly subjects. * denotes p<0.01 and ** p<0.001 when compared with base­
line values. 
group. Except for the values found at time 5 min no change in heart rate was 
observed after both tests. 
Baseline plasma norepinephrine levels were not significantly different between the 
groups (Table 2). Plasma norepinephrine increased significantly in both groups 
after oral glucose (Fig 3). After intravenous glucose a similar response was found 
in the normotensive group, while in the hypertensives no change in plasma nor­
epinephrine was found. However, this difference between both groups was not 
significant. The different response of plasma norepinephrine after both tests in the 
hypertensive elderly group almost reached the level of significance (p=0.06). 
Plasma epinephrine levels decreased in both groups after the two tests without 
any difference between groups and between tests (Fig 3). 
Intravenous glucose loading resulted in a rapid increase of plasma glucose and 
plasma insulin with an observed maximum at time 15 min and a sluggish decrease 
thereafter (Fig 4). After oral glucose the maximum levels of plasma glucose and 
plasma insulin were reached at time 60 min. No difference between the groups 
was found in the plasma glucose and plasma insulin response after both types of 
tests. Analysis of the insulin curves showed a significant difference in either group 
between both tests. 
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Figure 4 Mean values of plasma glucose and plasma insuline after oral (circles) 
and intravenous (dots) glucose loading in normotensive and hypertensive elderly 
subjects. * denotes p<0.01 and ** p<0.001 when compared with baseline values. 
Discussion 
This study demonstrates that in normo- and hypertensive elderly subjects, oral 
glucose loading lowered BP substantially within 30 min after the intake of the glu-
cose solution. The magnitude of the reduction in MAP was almost twice as high in 
hypertensive as in elderly normotensives. In contrast, rapid intravenous injection 
of glucose led to an almost immediate fall of BP which returned to baseline values 
within 10 min after the start of the glucose injection and remained unchanged for 
the following two hours of observation. 
The immediate fall of BP after administration of glucose 40% iv can be explained 
by the well-known vasodilating effect of rapidly and intravenously administered 
hypertonic solutions. All subjects experienced a flush and transient warm sensa-
tions. This hypotensive effect of hypertonic solutions (but probably also radio-
graphic contrast media) should be borne in mind when these are administered to 
elderly and patients with autonomic failure [10]. 
Insulin may have vasodilator effects. In patients with chronic autonomic failure 
and in diabetic patients, intravenous insulin administration caused a decrease of 
BP [11,14]. Several studies demonstrated that insulin infusions in conscious dogs 
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resulted in a vasodilator effect of skeletal muscle vasculature [15,16]. In addition, 
intra-arterial infusions of insulin in the forearm of healthy young volunteers, cau-
sed an increase in forearm blood flow and a decrease in forearm vascular resistan-
ce. This vasodilator effect of insulin can be inhibited by pretreatment with propra-
nolol, which suggests a beta adrenergic mechanism [17]. In the present study it is 
unlikely that a direct vasodilator effect of insulin plays an important role in the fall 
in BP after oral glucose, since we did not observe any effect of intravenous glucose 
administration on BP. Although the maximum insulin levels after oral glucose 
were higher than after intravenous glucose, this difference cannot account for the 
difference in BP response, since insulin levels at time 30 min, when a significant 
drop of BP occurred after oral but not after intravenous glucose loading, were not 
significantly different in either type of test. 
The effects of both types of loading tests on sympathetic nervous system activity 
can be derived from changes in plasma norepinephrine. The clearance of plasma 
norepinephrine has been reported to increase or to remain unchanged after incre-
ments in endogenous insulin release and, therefore, cannot explain the increase of 
plasma norepinephrine concentrations [18]. Furthermore, it is unlikely that the 
rise in plasma norepinephrine is derived from an enhanced secretion by the adre-
nal medulla, because plasma epinephrine decreased. The increase of plasma nore-
pinephrine after oral glucose loading may therefore reflect an activation of the 
sympathetic nervous system, elicited by the fall in BP. Indeed, when in the hyper-
tensive elderly subjects glucose was given intravenously, no change in BP and 
plasma norepinephrine was found. In the normotensive elderly, however, plasma 
norepinephrine showed a similar increase after intravenous and oral glucose loa-
ding. This increase of plasma norepinephrine after intravenous glucose, in the 
absence of an effect on BP, might reflect an insulin-mediated stimulation of sym-
pathetic nervous system activity, as was found in young volunteers [18], in diabe-
tic patients without neuropathy [19] and in dogs [15]. The diverging effects of 
intravenous glucose loading on plasma norepinephrine responses between both 
elderly groups are difficult to explain, unless we consider a relative impairment of 
insulin-mediated activation of the sympathetic nervous system in hypertensive 
elderly patients, as was found in diabetic patients with autonomic neuropathy 
[19]. Finally, non-specific stimuli from the gastro-intestinal tract may contribute 
to the degree of sympathetic nervous system activation. Both oral fructose [5] and 
oral xylose loading [20] lead to an increase of plasma norepinephrine, without a 
concomitant rise of plasma insulin. On the other hand, preliminary data of our 
laboratory have shown that an isovolumic water loading does not induce an 
increase in plasma norepinephrine in hypertensive elderly subjects. 
In the light of a possible role for insulin in postprandial BP reduction, a stimula-
tive effect of insulin on the sympathetic nervous system and a vasodilating action 
of insulin are difficult to reconcile, unless interaction of insulin and norepineph-
rine could be demonstrated. Indeed, in several studies, insulin was found to 
impair the peripheral action of norepinephrine [21,22], and to facilitate the take-
up of norepinephrine at the nerve terminals [23]. 
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In conclusion, the mechanism of postprandial BP reduction is still unknown. 
Based on the findings that BP only falls after a meal or oral glucose loading, but 
not after oral fructose or intravenous glucose loading, we suggest that interference 
of insulin with a by age or disease diminished sympathetic response to splanchnic 
vasodilation, may be responsible for postprandial BP reduction in the elderly. 
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CHAPTER V 
The influence of oral glucose loading on 
baroreflex function in the elderly 
Abstract 
Blood pressure (BP) in the elderly may decrease after a meal or after oral glucose 
loading. It has been suggested that eating may affect BP homeostasis through an 
insulin-induced blunting of baroreflex sensitivity. We investigated the effects of 
oral glucose loading on baroreflex sensitivity in young normotensives and in 
elderly normo- and hypertensive subjects. BP was measured by a new non-inva-
sive device, Finapres, which measures BP continuously in the finger. In both 
elderly groups mean arterial pressure fell significantly after the glucose load (by 11 
± 1 mm Hg, p<0.001 in the hypertensives and by 8 ± 2 mm Hg, p<0.01 in the 
normotensive subjects), whereas no change in BP was found in the young group. 
Baroreflex sensitivity was lower in both elderly groups than in young normoten-
sives. Glucose loading had no influence on baroreflex sensitivity in the three 
groups. Therefore, we concluded that other factors are involved in the phenome-
non of postprandial BP reduction in the elderly. 
Introduction 
It has been known for several years that blood pressure (BP) in the elderly may 
fall after a meal [1,2]. This phenomenon is related to BP level and age [1,2]. A 
similar reduction of BP can be found after oral glucose loading [3], but not after 
oral fructose [3] or intravenous glucose loading [4]. The fall in BP after oral glu-
cose starts about 15 min after ingestion and reaches its maximum within about 60 
min [4]. The decrease in BP after oral glucose can completely be prevented by pre-
treatment with the somatostatine analogue octreotide (SMS 201-995) [5]. These 
effects of octreotide are possibly mediated by suppression of insulin secretion. 
Therefore we consider that insulin might play an important role in the phenome-
non of postprandial hypotension. Lipsitz et al suggested that eating may affect BP 
homeostasis in the elderly through insulin-induced blunting of baroreflex sensiti-
vity [1]. This suggestion was based on the findings of Appenzeller et al who found 
that oral glucose decreased baroreceptor response to Valsalva maneuver in young 
and old patients with cerebrovascular diseases or peripheral neuropathy [6]. 
The present study was designed to investigate whether a decrease of baroreflex 
function after oral glucose loading may contribute to the postprandial fall of BP in 
the elderly. 
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Methods 
For this study three groups of subjects, recruited by a newspaper announcement, 
were studied: elderly hypertensives (EH), elderly normotensives (EN) and young 
normotensives (YN). All persons were healthy and no participant had a history of 
myocardial infarction, congestive heart failure, cerebrovascular accident, diabetes 
mellitus, chronic respiratory disease or mental deterioration. None of the elderly 
had a history of falls. All elderly subjects were 70 years or older. All EH had 
uncomplicated essential hypertension and had not taken antihypertensive medica-
tion for at least two weeks before the study. The clinical characteristics of the 
three groups are listed in Table 1. The two elderly groups did not differ in age, 
Quetelet's index or heart rate but did so in BP. The study was approved by the 
local ethical committee and all subjects gave written informed consent. 
Table 1 Clinical characteristics (mean ± SD) of Young Normotensives (YN), 
Elderly Normotensives (EN) and Elderly Hypertensives (EH). 
Sex (men/women) 
Age (years) mean 
range 
Quetelet index (kg/m2) 
Syitohc BP (mm Hg) 
Diastolic BP (mm Hg) 
Heart rate (beats/mm) 
YN 
(n=10) 
5 / 5 
26± 4 
21-32 
21± 2 
115± 7 
67± 6 
61± 6 
EN 
(n=15) 
6 / 9 
76± 4 
71-84 
26± 3 
141± 12 
79± 9 
62± 8 
EH 
(n=15) 
7 / 8 
73± 3 
70-80 
28_L 3 
185+18 
97± 9 
66±10 
p<0.01 versus young normotensives. 
p < 0 01 versus elderly normotensives. 
BP = blood pressure. 
All studies were carried out in the morning after an overnight fast. In each subject 
an oral glucose loading test was performed. Glucose was given in a dose of 75 
gram in 300 ml of water. At time 0 min the subjects consumed the glucose solution 
within 5 min. A 21 gauge butterfly needle was inserted 30 min before the start of 
the test in an antecubital vein and kept patent with physiologic saline. During the 
study the subjects stayed in the supine position. Before and 60 min after glucose 
ingestion blood samples were collected for determination of glucose, insulin and 
plasma catecholamine levels [7], and BP and heart rate were measured conti-
nuously during 5 min using the Finapres method. All BP and heart rate values 
were averaged and considered as the mean BP and heart rate. The Finapres (TNO-
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Finapres, model 5, The Netherlands) uses the volume clamp method of Penaz and 
is a fully automated instrument that allows a continuous non-invasive measure-
ment of finger arterial pressure. The details of this method have been described 
elsewhere [8,9]. 
Baroreflex sensitivity was estimated both with the phenylephrine and nitroglyce-
rin method [10], by graded intravenous bolus injections, beginning with a dose of 
50 ¿ig and increasing the dose with 50 /ig until a change in systolic BP of about 20 
mm Hg was obtained or a maximum of 150 /Ag was reached. Systolic pressures for 
each beat and corresponding RR interval were recorded with a personal computer 
and the slope of the linear regression line was calculated. In each subject three 
injections of both drugs were given before and 60 min after glucose injection. The 
average of the three slopes of the regression lines was considered to represent the 
baroreflex sensitivity. 
Statistical comparisons between paired and unpaired observations were made 
with Student's t-test when appropriate, otherwise Wilcoxon's signed rank and 
ranked sum tests were used. A p-level of 0.05 (two-sided) or less was considered 
to be of statistical significance. Correlation coefficients were calculated according 
to Pearson or to the non-parametric Spearman's rank correlation test. All values 
given in tables and text are expressed as mean ± standard error of the mean, unless 
indicated otherwise. 
Results 
In Table 2 all baseline hemodynamic and biochemical data of the three groups are 
listed. The mean changes of systolic BP, diastolic BP, mean arterial pressure and 
heart rate at 60 min after the glucose loading are presented in Fig 1. In both elderly 
Table 2 Baseline values in the three groups (mean ± sem). 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Mean arterial pressure (mm 
Heart rate (beats/min) 
Glucose (mmol/1) 
Insulin (mU/1) 
Norepinephrine (nmol/1) 
Epinephrine (nmol/1) 
Hg) 
YN 
125 ± 4 
64 ± 2 
81 ± 3 
61 ± 2 
4.1 ± 0 . 1 
6 ± 1 
0.95 ±0 .15 
0.13 ±0.02 
EN 
135 ± 5 
64 ± 2 
87 ± 3 
62 ± 2 
4.9 ± 0.2s 
8 ± 1 
1.66±0.145 
0.13 ±0 .02 
EH 
181 ± 4 • 
84 ± 3 · ' 
1 0 7 ± 5 : ; -
66 ± 3 
5.0 ± 0.2 
10 ± 2 
1.68 ±0 .30 
0.13 ±0 .02 
§ pSO.01 versus young normotcnsiveb. 
pSO.001 versus elderly normotensivcs. 
BP = blood pressure. 
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Figure 1 Mean changes of blood pressure and heart rate one hour after oral glu­
cose loading in young normotensives (YN), elderly normotensives (EN), and 
elderly hypertensive subjects (EH). 
* denotes p<0.05, ""·' p<0.01 and '·"·"'' p<0.001 when compared with baseline 
values. 
groups mean arterial pressure fell significantly after the glucose loading whereas 
in the YN mean arterial pressure remained essentially unchanged. In none of the 
subjects the fall of BP caused any subjective symptoms. In all three groups an 
increase of heart rate was observed, without statistically significant differences 
between groups. 
The results of baroreflex sensitivity are shown in Table 3. Baroreflex sensitivity, as 
established by both methods, in the normo- and hypertensive elderly groups were 
significantly less than that of the YN. Furthermore, the values in the EH were 
lower than that of EN. Glucose loading has no significant influence on baroreflex 
sensitivity in the three groups, nor with the phenylephrine method nor with the 
nitroglycerin method. When the change in mean arterial pressure was correlated 
with baroreflex sensitivity, a weak but significant correlation was found; r=0.50, 
p<0.01 for the phenylephrine method and r=0.49, p<0.01 for the nitroglycerin 
method. 
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Table 3 Values of baroreflex sensitivity (ms/mm Hg) before and after oral glu­
cose loading. 
Young Normotensives 
Elderly Normotensives 
Elderly Hypertensives 
Phenylephrine 
before 
30.4 ± 2 7 
8 0 ± 0 9SS 
5.8 ± 0.9 
afier 
30.2 ± 3.2 
9.4 ± 0.9 
5.1 ±0.7 
Nitroglycerin 
before 
14.9 ±2.2 
6.3 ± 0 9§ 
3.1 ±0.4 
after 
13.1 ± 1 6 
5.9 ± 1.2 
2.8 ± 0.4 
§ p < 0 01 and §§ pSO.OOl versus young normotensives 
p < 0 01 versus elderly normotensives 
Δ Glucose 
(mmol/l ) 
4 -
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Figure 2 Mean changes of glucose, insulin, norepinephrine and epinephrine one 
hour after oral glucose loading in young normotensives (YN), elderly normotensi­
ves (EN), and elderly hypertensive subjects (EH). " denotes p<0.05, ' * p<0.01 
and ''''•'* p<0.001 when compared with baseline values. 
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Oral glucose administration resulted in an increase of plasma glucose concentra-
tion (Fig 2). Baseline glucose levels were higher in the elderly groups than in YN. 
There was no difference between the groups in the increase of plasma glucose. In 
all groups plasma insulin levels rose significantly after the glucose load. The 
increase of plasma insulin was higher in EH when compared with EN. There was 
no correlation between the increase in plasma insulin and the decrease in mean 
arterial pressure. 
Baseline plasma norepinephrine levels were significantly higher in both elderly 
groups than in the YN group, whereas no difference could be found between EN 
and EH. Glucose loading resulted in an increase in norepinephrine level of 37 ± 
10% (p<0.01) in YN, 55 ± 14% (p<0.001) in EN and 29 ± 7% (p<10.01) in EH. 
The percentual or absolute changes of plasma norepinephrine between the groups 
were not significantly different. In all groups plasma epinephrine levels decreased 
significantly after oral glucose without any difference between the groups. 
Discussion 
An important role for carbohydrates and insulin in the postprandial BP reduction 
in the elderly was first proposed by Lipsitz et al [1]. Apparently the hypotensive 
effects of carbohydrates are especially related to oral glucose, since we previously 
found that BP decreases after oral glucose loading but not after oral fructose loa-
ding [3J. Using the Finapres device, the present study confirms the BP-related 
decrease in BP after an oral glucose load in the elderly. A slight and insignificant 
increase of mean arterial pressure was found in young normotensives. 
The Finapres provides a BP device with the possibility to measure BP and heart 
rate continuously and noninvasively. The BP values measured with this method 
are slightly lower than intra-arterial recordings [8,9]. However, this device fol-
lows intra-arterial patterns faithfully. It was therefore concluded that because of 
the inherent risks of intra-arterial BP monitoring, the Finapres can replace most 
intraarterial pressure recordings [8]. The recently developed method of estimating 
baroreflex sensitivity by means of spectral analysis creates the possibility of a 
completely non-invasive measurement of baroreflex sensitivity [11]. 
Since baroreflex sensitivity decreases with BP and age [12,13,14], a further 
decrease of baroreflex function in response to glucose and/or insulin could theo-
retically be responsible for an insufficient activation of the sympathetic nervous 
system. In elderly subjects, a by oral glucose induced vasodilation of splanchnic 
vasculature and an impairment of sympathetic nervous system activation may 
result in a fall in BP. However, this study clearly shows that baroreflex function, 
as established by the phenylephrine and nitroglycerin method, was not affected 
by oral glucose loading. In contrast to our results, Appenzeller et al found that 
oral glucose decreased baroreceptor responses in patients with cerebrovascular 
disease or diseases affecting baroreceptor function [6]. In their study baroreceptor 
66 
function was assessed during the release phase of valsalva maneuver. Additional 
support for a decreased sensitivity of baroreceptor function by insulin was also 
derived from some other studies [15,16]. Miles et al have shown that after intrave-
nous insulin in normal and diabetic subjects, head-up tilting resulted in a greater 
fall in mean arterial pressure than during tilting without insulin [15]. Similar 
results were found by Page et al who studied patients with diabetes and autono-
mic neuropathy [16]. From these experiments it was suggested that insulin admi-
nistration might impair baroreflex mechanisms [1]. 
The values of baroreflex sensitivity as established by the nitroglycerin method 
were lower than found by using phenylephrine. This difference is probably due to 
different aspects of baroreflex function which are measured. In addition, it has 
been demonstrated that the correlation among both measurement techniques is 
very low [10]. 
Although we did not find any effect of oral glucose loading on baroreceptor func-
tion, an influence of insulin at another level of the sympathetic nervous system 
cannot be excluded. Firstly, insulin has a direct stimulatory effect on the sympa-
thetic nervous system, even in the absence of hypoglycemia [17]. On the other 
hand, administration of insulin to patients with autonomic failure causes a 
decrease of BP [18]. These contrasting findings are difficult to reconcile, unless 
interaction of insulin and norepinephrine, at the level of the norepinephrine 
receptors, could be demonstrated. Indeed, in several studies, insulin has been 
found to impair the peripheral action of norepinephrine [19,20], and to facilitate 
the take-up of norepinephrine at the nerve terminals [21]. Secondly, insulin may 
have vasodilator effects. It has been demonstrated that insulin infusions in cons-
cious dogs resulted in a vasodilator effect of skeletal muscle vasculature [22,23]. In 
addition, intra-arterial infusions of insulin in the forearm of healthy young volun-
teers, causes an increase in forearm blood flow and a decrease in forearm vascular 
resistance. This vasodilator effect of insulin can be inhibited by pretreatment with 
propranolol, which suggests a beta adrenergic mechanism [24]. On the bases of 
these studies we suggest that the fall in BP in the elderly after oral glucose or after 
meals is caused by a shift of blood volume to the splanchnic vasculature which is 
incompletely counterbalanced by activation of the sympathetic nervous system, 
and secondly that glucose related factors, such as insulin, may interfere with a 
normal sympathetic nervous system activation or may have direct vasodilator 
properties. However it is unlikely that a vasodilator effect of insulin primarily 
determines the fall in BP after oral glucose [4]. 
The basal concentration of plasma norepinephrine was higher in the elderly sub-
jects. It is generally agreed that norepinephrine increases with age [25,26], but it 
remains to be determined whether this is due to a reduced clearance of norepi-
nephrine [27] or to an increased rate of neuronal release [28]. Despite a greater fall 
in BP to oral glucose loading, the lower increase of plasma norepinephrine in the 
hypertensive elderly is in accordance with the age and BP related decrease of baro-
reflex sensitivity as found in this study and other studies [12,13,14]. 
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In conclusion, our data indicate that in the elderly BP decreases after oral glucose. 
Baroreflex sensitivity is diminished in the elderly, but oral glucose loading did not 
further decrease baroreflex sensitivity. Therefore, other factors such as interfe­
rence of insulin with a normal function of the sympathetic nervous system or 
vasodilator effects of insulin might be responsible for the fall in BP after meals or 
oral glucose. 
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CHAPTER VI 
The effect of oral glucose, protein, fat and water 
loading on blood pressure in hypertensive 
elderly subjects 
Abstract 
In elderly subjects blood pressure (BP) may fall after a meal. It can be reproduced 
by oral glucose, but the effect of fat and protein ingestion on postprandial BP is 
unknown. Furthermore, we hypothesized that vasoactive gastrointestinal hor-
mones are involved in the etiology of postprandial BP reduction. In 10 hyper-
tensive elderly subjects (mean age 74 ± 3 years), we studied the effects of oral glu-
cose, fat, protein and water loading on BP in relation to plasma concentrations of 
vasoactive intestinal polypeptide (VIP), somatostatin and insulin. Glucose, fat 
(cream) and protein (Protein 88®) were given in a dose of 75 gram in 300 ml of 
water. Glucose loading resulted in a decrease of mean arterial pressure by 14 ± 2 
mm Hg (p<0.001). In contrast, the ingestion of fat, protein or water appeared to 
have no influence on BP. Somatostatin increased after fat and protein loading, 
whereas VIP only increased after fat loading. These data indicate that postprandial 
BP reduction in the elderly is related to glucose related factors, since BP did not 
decline after fat or protein ingestion. The gut hormone VIP does not seem to play 
a role in this phenomenon. 
Introduction 
It has been known for several years that blood pressure (BP) in the elderly may 
fall after a meal [1,2]. This phenomenon is related to baseline BP and age [2,3]. We 
have previously reported that in normo- and hypertensive elderly subjects a com-
parable reduction of BP can be found after oral glucose loading [3], but not after 
oral fructose [3] or intravenous glucose loading [4]. These findings may indicate 
that oral glucose loading induces a specific vasodilation of splanchnic vasculature, 
possibly mediated by stimulation of vasoactive gastrointestinal hormones. On the 
other hand, it has been suggested that insulin may play an important role in post-
prandial hypotension by interference with a normal function of the sympathetic 
nervous system [1,3]. Although the mechanism of postprandial BP reduction in 
the elderly and in patients with autonomic failure still remains to be elucidated, it 
seems to be clear that the aforementioned factors, in addition to a by age and BP 
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diminished baroreflex sensitivity, are involved in the phenomenon of postprandial 
BP reduction. However, it is also of interest to know whether protein, fat or 
water may interfere with postprandial BP homeostasis. The present study was 
designed to investigate the effects of different food components on BP in relation 
to plasma concentrations of vasoactive intestinal polypeptide (VIP), somatostatin 
and insulin in healthy hypertensive elderly subjects aged 70 years or older. 
Methods 
Ten hypertensive elderly subjects (4 men, 6 women), aged 70 years or older, were 
recruited by a newspaper announcement. Antihypertensive drugs had been with-
drawn for at least two weeks before the study. None of the subjects had a history 
of myocardial infarction, cerebrovascular accident, congestive heart failure, or 
diabetes mellitus. The clinical characteristics of the study group were: age 74 ± 3 
(SD) years (range 70 to 80 years), Quetelet index 26 ±3 (SD) kg/m2, BP 170/93 ± 
15/10 (SD) mm Hg and heart rate 69 ± 8 (SD) beats/minute. The study was 
approved by the local ethical committee and all subjects gave written informed 
consent. 
In each subject an oral glucose, fat, protein and water load was performed in a ran-
dom order, on separate occasions with an interval of at least 3 days. All test solu-
tions were made up to 300 ml with water containing the same amount of nutrients 
(75 gram). Glucose was given in a dose of 75 g in 300 ml of water. For the protein 
solution we used 85 g of Protein 88® (Wander, Sando? BV, The Netherlands) in 
300 ml of water, containing 75 g whey protein, 1.7 g fat and 1.7 g lactose. Fat was 
given as 215 g cream in 300 ml of water. This solution contains 75 g fat, 4.3 g 
protein and 6 g carbohydrates. For the water loading 300 ml of water at room 
temperature was used. 
All studies were carried out in the morning after an overnight fast. At time 0 min 
the subjects consumed the test solution within 5 min. During the study the 
patients remained in a semi-recumbent position. BP was measured by an automa-
tic recorder (Arteriosonde 1225, Roche) and heart rate was calculated from an 
ECG-recording at 5 min intervals from —30 to 150 min. Three BP- and heart rate 
measurements, taken from time —10 to 0 min, were averaged and considered as 
the baseline BP and heart rate and further denoted as time 0 min. This value and 
the means of the 3 values around the 30, 60, 90, 120 and 150 min time points (i.e. 
25, 30, 35 min) were used in the analyses. A 21 gauge butterfly needle was inserted 
in an antecubital vein 30 min before the test solutions were given and kept patent 
with 154 mmol/1 NaCl. At time 0, 30, 60, 90,120 and 150 min blood samples were 
collected for determination of glucose, insulin, triglycerides, VIP, somatostatin 
and plasma catecholamines. Plasma catecholamines were measured using a 
radioen/ymatic assay [5]. Samples for determination of VIP and somatostatin 
were collected in EDTA tubes containing 0.5 ml aprotinin (Trasylol®). The sam-
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pies were centrifuged immediately and the plasma stored at —20 0 C until assay. 
VIP was measured by radioimmuno assay [6] using labeled VIP obtained from 
New England Nuclear (NEN, Drciech, FRG), standard VIP and antibody obtai­
ned from UCB, Bioproducts (Braine L'AUeud, Belgium). The sensitivity of this 
assay was such that it could detect changes of 1.5 pmol/1 with 95% confidence. 
Somatostatin was measured by radioimmuno assay [7] using labeled somatostatin, 
standard and antibody obtained from Amersham, Belgium. The sensitivity of this 
assay was such that it could detect changes of 0.3 pmol/1 with 95% confidence. All 
samples were analyzed in duplicate at the same time in each assay. 
Statistical comparisons between paired and unpaired observations were made 
with Student's t tests when appropriate; otherwise Wilcoxon's signed rank and 
ranked sum tests were used. To reduce the overall probability of a type I error, a 
level of significance of p<0.01 (two-sided) was employed. The Kruskall-Wallis 
test was used to compare baseline values in the four tests. Comparisons between 
curves were made with a distribution-free analysis of variance [8]. Firstly, all cur­
ves were analyzed together. In this test a ρ value of 0.05 or less was considered to 
be statistical significant. When a difference was found, the curves after glucose, fat 
and protein loading were independently compared with the curves following 
water loading. To study the independent effects of glucose, insulin, VIP and 
somatostatin on BP responses one hour after the ingestion of the test solutions, 
a multiple regression analysis was performed within the groups. Mean arterial 
pressure (MAP) was calculated as the sum of diastolic BP and one third of pulse 
pressure. All values given in tables and text arc expressed as mean ± standard 
error of the mean, unless indicated otherwise. 
Results 
In Table 1 all baseline hemodynamic, biochemical and hormonal data of the four 
tests are listed. No significant difference was found between the baseline values in 
the four test groups. Fig 1 presents the changes in BP and heart rate after the four 
loading tests. 
After oral glucose systolic BP decreased significantly within 30 min and reached 
its maximum at time 60 min (15 ± 3 mm Hg, p<0.001). A similar pattern was 
found for the change in diastolic BP with a maximum decrease of 13 ±2 mm Hg 
(p<0.001). MAP fell from 111 ± 2 to 97 ± 2 mm Hg (13%, p<0.001). After fat, 
protein and water loading BP remained essentially unchanged. The ρ values for 
the comparison of the BP-curves obtained with the four test solutions are given in 
Table 2. The change of MAP following oral glucose was significantly greater than 
the change of MAP after water loading. 
After oral glucose, heart rate increased from 69 ± 3 to 74 ± 3 (p<0.01) at time 30 
min. Following fat, heart rate increased from 70 ± 4 to 75 ± 4 (p<0.01) at time 60 
min and to 77 ± 4 (p<0.01) at time 150 min. Protein loading did not affect heart 
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Table 1 Baseline values before ingestion of the four test solutions 
MAP (mmHg) 
Heart rate (bpm) 
Glucose (mmol/1) 
Insulin (mU/1) 
Triglycerides (mmol/1) 
Norepinephrine (nmol/l) 
Epinephrine (nmol/l) 
VIP (pmol/1) 
Somatostatin (pmol/l) 
Glucose 
111 ± 2 
69 ± 3 
4.9 ± 0.2 
10 ± 2 
1.6 ± 0 . 3 
1.73 ±0 .24 
0.14 ±0 .02 
1 7 ± 2 
6 ± 1 
Fat 
108 ± 3 
70 ± 4 
4.9 ± 0.2 
10 ± 2 
1.3 ±0 .2 
1.84 ±0.31 
0.13 ±0 .03 
1 4 ± 2 
6 ± 1 
Protein 
111 ± 4 
70 ± 4 
5.0 ±0 .2 
12 ± 2 
1.7 ± 0 . 3 
1.65 ±0 .23 
0.15 ±0 .04 
1 7 ± 2 
5 ± 1 
rate. After water a slight decrease of heart rate was observed. Comparison 
between the heart rate curves showed a significant difference between glucose ver-
sus water loading and fat versus water loading. 
The course of the glucose and insulin values is depicted in Fig 2. Following oral 
glucose loading, plasma glucose concentration rose to a maximum of 9.3 ± 0.7 
mmol/1 (p<0.001) at time 60 min. After fat and protein loading a.slight but signifi-
cant decrease was found, but water ingestion did not affect glucose levels. Oral 
glucose resulted in an increase of insulin levels, with a maximum at time 90 min. A 
smaller but also significant rise was observed 30 and 60 min after protein loading, 
and 30 min after fat. Water was again without effect. The curve of plasma insulin 
following oral glucose was significantly different from those after fat, protein and 
water loading. 
Initially, fat loading induced a small decrease of plasma triglycerides but at time 90 
min a significant increase of 0.3 ± 0.1 mmol/1 (p<0.01) was found. Maximum 
triglyceride levels (2.4 ± 0.3 mmol/1, p<0.001) were reached at time 150 min. 
Oral glucose and protein loading both resulted in a decrease of plasma triglyceri-
des whereas water loading did not have any effect. 
The values of plasma catecholamines are shown in Fig 3. After both oral glucose 
and fat loading a significant increase in plasma norepinephrine of 37% and a signi-
ficant decrease in plasma epinephrine was found. Protein and water loading had 
no influence on the plasma concentrations of norepinephrine and epinephrine. 
Comparison between the curves of norepinephrine showed that there was a diffe-
rence between glucose versus water loading and fat versus water loading. There 
was no difference between the curves of epinephrine when analyzed together. 
The data of somatostatin and VIP are given in Fig 4. Oral glucose and water loa-
ding did not result in a change of somatostatin and VIP levels. A marked increase 
of plasma somatostatin (192%) was found after fat and a smaller increase of 69% 
Water 
1I0±3 
74 ± 4 
5.1 ±0.2 
13 ±2 
1.5 ±0.3 
1.94 ± 0.38 
0.10 ±0.02 
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Δ Mean arterial pressure (mmHg) 
glucose fat 
.1 
30 90 ISO 
Figure 1 Changes of mean arterial pressure and heart rate after ingestion of the 
four test solutions. * denotes p^O.01 and ** p<0.001 when compared with baseline 
values. 
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Figure 2 Mean plasma glucose and insulin concentrations before and after glucose 
(dots), fat (open triangles), protein (solid triangles) and water (circles) loading. 
* denotes p<0.01 and :;"::' p<0.001 when compared with baseline values. 
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Figure 3 Mean plasma norepinephrine and epinephrine concentrations before 
and after the four test solutions. * denotes p^O. 01 and *''' p<0.001 when compared 
with baseline values. 
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Figure 4 Mean plasma somatostatin and vasoactive intestinal polypeptide (VIP) 
concentrations before and after the four test solutions. * denotes p<0.01 and 
** p<0.001 when compared with baseline values. 
78 
Table 2 P-values of analysis of variance between the different curves. 
MAP 
Heart rate 
Glucose 
Insulin 
Triglycerides 
Norepinephrine 
Epinephrine 
VIP 
Somatostatin 
NS = not significant 
All 
p<0.00l 
p < 0 01 
p<0.001 
p<0.001 
p<0.001 
p<0.05 
NS 
p<0.001 
pSO.001 
Glucose vs 
Water 
pSO.OOI 
p<0.05 
p<0.001 
p<0.001 
NS 
p<0.01 
-
NS 
NS 
Fatvs 
Water 
NS 
p<0.01 
NS 
p<0.05 
p<0.01 
p<0.05 
-
p<0.01 
p<0.001 
Protein vs 
Water 
NS 
NS 
NS 
pSO.Ol 
NS 
NS 
-
NS 
p<0.01 
after protein loading. The curves of somatostatin following fat and protein both 
differed from the curve after water loading. Only fat loading resulted in a signifi-
cant increase of plasma VIP levels, differing significantly from the curve after 
water loading. 
Regression analysis revealed that the change in glucose, insulin, VIP and somatos-
tatin concentrations were not significantly correlated with the change of MAP. 
All subjects completed the study without any problems. A few subjects voluntee-
red a heavy feeling in the upper abdomen during the fat loading. 
Discussion 
The data in this study document that BP in healthy hypertensive elderly subjects 
falls following oral glucose, but not so, however, after oral fat, protein and water 
loading. This glucose induced fall in BP is comparable in magnitude to the 
decrease in BP as found in previous studies after meals [2] or oral glucose [3]. To 
our knowledge, the effects of different nutrients on BP have only been studied in 
patients with autonomic failure. Mathias et al recently reported that BP in patients 
with autonomic failure not only falls after oral glucose loading, but also after fat 
and protein loading [9]. Fat loading, compared to glucose, had a smaller, slower 
and less sustained effect, while protein loading had a small, transient hypotensive 
effect. Hoeldtke et al reported on an elderly patient with autonomic neuropathy 
who developed a drop in BP of 60 - 80 mm Hg after dextrose, fat (Lipomul) and 
protein (Propac) loading [10]. 
The different test solutions as used in the present study were isovolemic. They 
contained the same amount of nutrients, but differed in osmolality. It is unlikely, 
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however, that differences in osmolality accounted for the different effects on BP 
Firstly, we previously found that fructose, administered in an isosmotic solution, 
as compared to glucose, had no influence on BP [3] Secondly, it has been demon­
strated that there are no changes in plasma electrolytes, osmolality and haemato-
cnt after a meal in patients with autonomic failure This suggests that a shift of 
fluid into the gut or a contraction in plasma volume is unlikely to be responsible 
[ И ] 
The results of the present study and of previous studies in which we found that BP 
only fell after oral glucose, but not after oral fructose [3] or intravenous glucose 
loading [4], suggest that oral glucose induces a specific vasodilation, possibly 
mediated by vasoactive gastrointestinal hormones Indeed, we found that pre­
treatment with a somatostatinc analogue octreotide (SMS 201-995) prevents the 
fall of BP after oral glucose loading [12] In the present study we measured VIP, 
which is known to have vasoactive properties [13,14J It can be hypothesized that 
splanchnic or systemic vasodilation after oral glucose is mediated by this gut pep­
tide, causing a shift of blood to the splanchnic area In the elderly this may lead to 
a fall in BP due to an insufficient activation of the sympathetic nervous system 
VIP infusions in man produce a dose-dependent decrease of diastolic BP with an 
increase in heart rate [15] However, the physiologic role of VIP in splanchnic 
vasodilation is not clear and it has been suggested that VIP may play a role as a 
neurotransmitter but not as a circulating hormone [14] After intraduodenal 
instillation of fat a rise occurs in plasma VIP [16] However, VIP is not released in 
healthy young subjects after ingestion of a meal [17] or oral glucose [18] In the 
present study we found a significant response of VIP only after fat loading, howe 
ver, wi thout a concomitant change of BP These data confirm our earlier report 
that oral glucose does not induce a rise in VIP in the elderly [12] and therefore, we 
conclude that VIP, as reflected in peripheral plasma concentrations, does not play 
an important role in postprandial BP reduction in the elderly 
It has been demonstrated that in normal human subjects, infusion of somatostatin 
reduced splanchnic blood flow by 3 0 % [19] Somatostatin has an inhibitory effect 
on virtually all gastrointestinal hormones [20] It can be argued that somatostatin 
plays a modulating role in splanchnic vasodilation by suppressing vasoactive gut 
peptides Indeed, our findings of an increase of somatostatin after fat and protein 
loading are in support of this theory, although apparently VIP is not involved 
It has been shown that in young volunteers, ingestion of carbohydrate, fat and 
protein meals increased superior mesenteric artery blood flow to the same extent 
[21] Drinking water [21] or a lactulose solution [22] did not affect superior 
mesenteric artery blood flow, indicating that the chemical nature of nutrients and 
not the volume per se is a factor that determines postprandial mesenteric vaso­
dilation Indeed, it became clear in dogs that postprandial intestinal hyperemia is 
related to the absorption and local oxidative metabolism [23] It still remains to be 
studied whether the nutrients fat, protein and carbohydrates cause different 
effects on splanchnic blood flow in the elderly 
80 
Other factors which may be responsible for the glucose-induced fall of BP in the 
elderly are a by age or disease diminished sympathetic response to splanchnic 
vasodilation, interference of insulin with a normal sympathetic nervous system 
function [24,25,26] and perhaps additional vasodilator effects of insulin. 
In patients with chronic autonomic failure and in diabetic patients, intravenous 
insulin administration caused a decrease of BP [24,27,28]. Several studies demon-
strated that insulin infusions resulted in a vasodilator effect in dogs and healthy 
man [29,30]. When oral glucose is given, the rise in plasma insulin, in addition to 
splanchnic vasodilation, might impose too great a burden on the homeostatic 
capacity of BP regulation. Against a role for insulin tells the absence in this study 
and previous studies [3,4,12] of a correlation between the increase of plasma insu-
lin and the decrease in BP after oral glucose loading. 
The effects of the loading tests on sympathetic nervous system activity can be 
derived from changes in plasma norepinephrine. Despite the fact that BP only fell 
after oral glucose, plasma norepinephrine increased not only after glucose but also 
after fat loading. The present results may indicate that the activation of the sympa-
thetic nervous system following oral nutrients is not only a response to a fall in 
BP. Indeed, it has been shown that also xylose [31] and fructose loading [3] induce 
an increase in plasma norepinephrine, without changes in BP. Therefore, non-
specific stimuli from the gastro-intestinal tract seem to contribute to the degree of 
sympathetic nervous system activation. 
In conclusion our data indicate that in hypertensive elderly subjects BP decreases 
only after oral glucose, but not after fat, protein or water loading. The gut hor-
mone VIP docs not seem to be involved in the etiology of postprandial hypoten-
sion. Therefore we suggest that glucose-related factors may be responsible for the 
fall in BP in the elderly. 
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CHAPTER VII 
Somatostatin analogue octreotide (SMS 201-995) 
prevents the decrease of blood pressure 
after oral glucose loading in the elderly 
Abstract 
In elderly subjects blood pressure (BP) may fall after a meal. The mechanism of 
this phenomenon is unknown, but it has been suggested that it may be mediated 
by insulin and/or vasoactive gut hormones. We studied in normo- and hyperten­
sive elderly subjects, the effects of the synthetic long-acting somatostatin analo­
gue octreotide (SMS 201-995) on the BP reduction that follows oral glucose admi­
nistration in subjects who are recumbent and on their postglucose plasma vaso­
active intestinal polypeptide (VIP) and insulin concentrations. After placebo 
treatment, mean arterial pressure fell by 15 ± 1 mm Hg (p<0.001) in the 10 
hypertensive subjects and by 7 ± 2 mm Hg (p<0.01) in the 10 normotensivc sub­
jects. In contrast, when 50 μ£ octreotide were given sc, BP did not change signifi­
cantly in either group. Oral glucose did not induce a rise in plasma VIP after cither 
octreotide or placebo administration. The postglucose rises in plasma glucose 
concentrations were similar after octreotide and placebo treatments in both 
groups. After placebo administration the postglucose plasma insulin levels increa­
sed from 79 to 519 pmol/1 in the hypertensive subjects and from 63 to 464 pmol/1 
in the normotensivc subjects, whereas after octreotide treatment plasma insulin 
increased only little in either group. These data indicate that treatment with 
octreotide holds promise for patients with symptomatic postprandial hypoten­
sion, and that VIP does not seem to play a role in this phenomenon. 
Introduction 
Blood pressure (BP) may fall in elderly subjects after a meal [1,2]. This pheno­
menon is related to BP level and age [1,2]. Although its clinical significance is 
uncertain, Lipsitz et al described eight institutionalized elderly patients with 
meal-related syncope and large postprandial BP declines [3]. In addition, patients 
with autonomic dysfunction may become hypotensive after a meal [4]. The 
mechanism of postprandial BP reduction is unknown, but an impaired sympathe­
tic reflex reactivity to splanchnic vasodilation might be responsible for it [1,5]. In 
earlier studies we found that the BP of elderly persons decreased after oral glucose 
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loading [5], but not after intravenous glucose [6] or oral fructose loading [5]. 
These findings indicated that oral glucose specifically induces vasodilation of 
splanchnic vasculature, possibly mediated by stimulation of vasoactive gastroin-
testinal hormones . O n the other hand, insulin may interfere with the normal func-
tion of the sympathetic nervous system [7,8,9]. Hoeldtke et al found that post-
prandial hypotension in patients with autonomic neuropathy was abolished by 
subcutaneous administration of the long-acting somatostatin analogue octreotide 
(SMS 201-995) [10]. Octreotide has been demonstrated to decrease not only the 
secretion of almost all gastrointestinal hormones [11], but also splanchnic blood 
flow [12]. This study was designed to investigate the effects of octreotide on BP 
after oral glucose administration in relation to plasma vasoactive intestinal poly-
peptide (VIP) and insulin concentrations in normo- and hypertensive elderly sub-
jects. 
Materials and methods 
Experimental subjects 
Ten hypertensive and 10 normotensive subjects, aged 70 years or older, were 
recruited by a newspaper announcement. Hypertension was defined as a supine 
systolic BP of more than 180 mm Hg or a supine diastolic BP of more then 95 mm 
H g measured after 20 min of rest at three consecutive visits using a standard 
sphygmomanometer . Antihypertensive drugs were withdrawn for at least two 
weeks before the study. N o n e of the subjects had a history of myocardial infarc-
tion, cerebrovascular accident, congestive heart failure, or diabetes mellitus. The 
study was approved by the local ethical committee, and all subjects gave written 
informed consent. The clinical characteristics of both groups are listed in Table 1. 
The two groups did not differ in age, Quetelct index (body weight divided by 
height2), or heart rate, but only in BP. 
Table 1 Clinical characteristics of study subjects 
Age (years) mean 
range 
Sex (men/women) 
Quetelct index (Kg/m2) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Heart rate (beais/min) 
Normotensive 
(n=10) 
74+ 4 
71 -83 
4 / 6 
27± 4 
135±11 
78± 6 
60± 9 
Hypertensive 
(n=10) 
74± 4 
70-80 
3 / 7 
26± 3 
183±16":-
100± 6* 
63±12 
* p<0.01 when compared with normotensive subjects 
BP = blood pressure 
Mean ± SD 
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Pilot study 
In a pilot experiment we studied the effect of 50 jag (1 ml) octreotide (in acetic 
acid) on BP and heart rate in 8 normotensive elderly subjects. After 30 min of rest 
in the supine position 1 ml octreotide or 1 ml placebo (154 mmol/1 NaCl) was 
given sc in randomized single blind order. BP and heart rate were measured at 5 
min intervals from —30 to 120 min. Mean arterial pressure (MAP) increased from 
94 ± 3 (SE) to 103 ± 3 mm Hg (p<0.01) after placebo treatment and from 98 ± 2 
to 104 ± 2 mm Hg (p<0.01) after octreotide. Calculation of the 95% confidence 
limits demonstrated no difference between the effects of placebo and octreotide. 
Heart rate did not change on cither occasion. 
Methods 
Each subject received octreotide and placebo (154 mmol/1 NaCl) followed by oral 
glucose in double blind randomized order with an interval of 1 week. All studies 
were carried out in the morning after an overnight fast. At time 0 min the subjects 
consumed 75 g glucose in 300 ml water within 5 min. Octreotide (50 /ug) or pla­
cebo was given sc 30 min before the glucose (time —30 min). During the study the 
subjects stayed in the supine position. BP was measured by an automatic recorder 
(Arteriosonde 1225, Roche) and heart rate was calculated from an ECG-recording 
at 5 min intervals from —30 to 120 min. The 3 BP— and heart rate measurements 
at —10, —5 and 0 min, were averaged and considered as the basal BP and heart rate 
(time zero values). This value and the means of the 3 values around the 30, 60, 90 
and 120 min time points (i.e. 25, 30, and 35 min) were used in the analyses. A 21-
gauge butterfly needle was inserted in an antecubital vein and kept patent with 154 
mmol/1 NaCl. At time zero, 30, 60 and 120 min blood samples were collected for 
measurement of glucose, insulin and VIP. Plasma glucose was measured with an 
autoanalyzer using the glucose oxidase method and plasma insulin was measured 
in duplicate by RIA. The samples for determination of VIP were collected in 
EDTA tubes containing 0.5 ml aprotinin (Trasylol®). The blood samples were 
centrifuged immediately, and the plasma was stored at —20 °C until assay. VIP 
was measured by RIA [13] using labeled VIP obtained from New England 
Nuclear (NEN, Dreiech, FRG) and standard VIP and antibody obtained from 
UCB, Bioproducts (Braine L'Alleud, Belgium). The sensitivity of this assay was 
such that it could detect changes of 1.5 pmol/1 with 95% confidence. All samples 
from an individual subject were analyzed in duplicate at the same time in each 
assay. 
Statistics 
Statistical comparisons between paired and unpaired observations were done by t 
test when appropriate; otherwise Wilcoxon's signed rank and ranked sum tests 
were used. To reduce the overall probability of a type I error, a level of signifi­
cance of p<0.01 was employed (Bonferroni's correction). The response curves 
were compared with a distribution-free analysis of variance [14]. In this test a ρ 
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level of 0.05 or less was considered to be statistically significant. To study the 
independent effects of insulin and VIP on BP responses multiple regression analy­
sis was performed. MAP was calculated as the sum of diastolic BP and one third of 
pulse pressure. All values given in the tables and text are expressed as the mean ± 
SE, unless indicated otherwise. 
Results 
Blood pressure and Heart rate 
Fig 1 and 2 shows the BP and heart rate measurements after placebo and octreo­
tide administration in the hypertensive and normotensive groups. In both groups 
MAP fell significantly after glucose administration following previous placebo 
administration. The percentage MAP decline after oral glucose was significantly 
greater in the hypertensive than in the normotensive subjects (p<0.05). In no sub­
ject did the fall in BP cause any subjective symptoms. In contrast, when octreotide 
was given before oral glucose, BP did not change in either group. In the hyper­
tensive group there was a significant difference in systolic BP, diastolic BP, and 
Systolic blood pressure Mean blood pressure 
(mmHg ) (mmHg) 
Diastolic blood pressure Heart rate 
(mmHg) (beats/mm) 
о placebo 
Figure 1 Mean (± SE) blood pressure and heart rate after glucose ingestion follo­
wing placebo or octreotide (SMS 201-995) administration in the hypertensive 
elderly subjects. The p-values shown represent the results of curve analysis between 
placebo and octreotide. * denotes p^O.Ol and ** p<0.001 when compared with 
baseline values (Time 0). 
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Figure 2 Mean (± SE) blood pressure and heart rate after glucose ingestion follo­
wing placebo or octreotide (SMS 201-995) administration m the normotensive 
elderly subjects. The p-values shown represent the results of curve analysis between 
placebo and octreotide. ' denotes ρ<0.01 and "'"' p<0.001 when compared with 
baseline values (Time 0). 
MAP after octreotide administration compared to those after placebo. In the nor­
motensive group there was a difference only in diastolic BP and MAP. There was 
no difference in baseline (Time zero) BP after octreotide or placebo treatment in 
either group. 
In both groups heart rate increased significantly after placebo. After octreotide, 
there was a slight but significant increase in heart rate at the end of the study 
period in both groups. However, no significant difference was found in the course 
of heart rate between octreotide and placebo treatments in either group. The base­
line heart rates were similar in the hypertensive group, whereas in the normoten­
sive group the baseline heart rate after octreotide treatment was lower than that 
after placebo (p<0.05). 
Plasma Glucose and Insulin 
The plasma glucose and insulin values are shown in Fig 3. The mean plasma 
glucose concentrations increased after oral glucose administration after octreotide 
and placebo treatments in both groups. Comparison of the glucose response 
curves revealed no significant differences between octreotide and placebo treat­
ments in either group. However, the rise of glucose at 30 min was significantly 
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Figure 3 Mean (± SE) plasma glucose and insulin concentrations after glucose 
ingestion following placebo or octreotide (SMS 201-995) administration m the nor­
motensive and hypertensive elderly subjects. The p-values shown in the figure 
represent curve analysis between placebo and octreotide. :: denotes p<0.01 and 
** p<Q.001 when compared with baseline values (Time 0) or between baseline 
values. 
lower after octreotide than after placebo in both groups. Baseline (Time zero) 
plasma glucose and insulin levels were significantly lower after octreotide than 
after placebo treatment in both groups. There was no difference in either group in 
the increase in insulin after oral glucose when placebo was given, but octreotide 
administration strongly inhibited the insulin response. Indeed, only at 120 min 
did plasma insulin increase slightly. 
Plasma VIP 
The plasma VIP values are shown in Table 2. Oral glucose did not result in a 
change in plasma VIP levels in the hypertensive group, but plasma VIP decreased 
slightly in the normotensive group. Octreotide administration did not change the 
basal plasma VIP levels or the VIP levels after oral glucose. Regression analysis 
revealed no correlations between the changes in plasma insulin or VIP concentra­
tions and the reduction in MAP. 
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Table 2 Plasma VIP concentrations (pmol/l) after glucose ingestion following 
placebo and octreotide administration in normotensive and hypertensive elderly 
subjects. 
Time (mm) 
0 
30 
60 
120 
Normotensive 
placebo 
18± 1 
16 ± 2 
16 ± 1 
15± 1 
octreotide 
16 ± 2 
19 ± 2 
18 ± 2 
16 ± 2 
Hypertensive 
placebo 
1 7 ± 2 
1 8 ± 2 
1 7 ± 2 
1 7 ± 1 
octreotide 
1 8 ± 1 
1 7 ± 1 
17 + 2 
1 7 ± 2 
p<0 01 when compared with basal values 
Side effects 
The sc injections of octreotide were uncomfortable because of the acetic acid solu-
tion. Some subjects had frequent defecation and slight abdominal pain during the 
afternoon and evening on the day of the study. 
Discussion 
Falls are an important cause of morbidity and even mortality in the elderly. Post-
prandial BP reduction may be of clinical importance, since Lipsitz et al recognized 
that syncope in the elderly is sometimes related to postprandial BP reductions [3]. 
Also, in patients with autonomical failure, large falls in BP after a meal have been 
reported [4,10]. Thus, postprandial BP decreases may precipitate dizziness, falls, 
or syncope. Because postprandial hypotension is related to basal BP [1,2], we stu-
died both normotensive and hypertensive elderly subjects. 
We found that a single 50 /ig sc injection of the somatostatin analogue octreotide 
completely prevented the fall of BP after oral glucose in recumbent normotensive 
and hypertensive elderly subjects. This octreotide dose is known to markedly 
reduce plasma insulin and gut hormone concentrations [11]. In addition, we con-
sidered this dose as appropriate for the purpose of the study, since in a pilot study 
it had no effect on BP or heart rate in recumbent elderly subjects. Whether lower 
doses will be equally effective in preventing postprandial BP reduction in the 
elderly needs to be determined. 
The mechanism by which octreotide exerted its beneficial effect on postprandial 
recumbent BP include suppression of insulin and/or vasoactive gastrointestinal 
hormone secretion and reduction in splanchnic blood flow. 
Splanchnic or systemic vasodilation after oral glucose could be mediated by 
vasoactive gut hormones, such as VIP or neurotensin [15], causing a shift of blood 
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to the splanchnic area. In the elderly this could lead to a fall in BP, especially if 
there was insufficient activation of the sympathetic nervous system, due to an age 
and BP related decrease in baroreflex sensitivity [16,17]. 
VIP infusions in man produce a dose-dependent increase in heart rate and a 
decrease in diastolic BP [18]. In healthy young subjects, plasma VIP concentra-
tions did not change significantly after ingestion of a meal [19] or oral glucose 
[20], and we found no postglucose change in plasma VIP levels in elderly subjects 
after either octreotide or placebo administration. Therefore, we conclude that VIP 
does not play an important role in the postprandial BP reduction. However, other 
vasoactive gut hormones, such as substance-P, neurotensin, or bradykimn, could 
be involved in the hypotensive effects of glucose administration. 
The beneficial effect of octreotide on postprandial BP reduction could be due to a 
direct effect on splanchnic hemodynamics. Meals or oral glucose may increase 
superior mesenteric arterial blood flow [21,22]. Infusion of somatostatin or 
octreotide decreases splanchnic blood flow, possibly by a direct action on vascu-
lar smooth muscle [12,23,24] 
The effects of octreotide on carbohydrate metabolism are apparent from the 
plasma glucose and insulin concentration curves. Somatostatin may be an inhibi-
tory modulator of nutrient absorption [25], and impaired glucose absorption has 
been reported during somatostatin infusions [24]. We found that plasma glucose 
rose more slowly after octreotide, while the increased glucose levels at the end of 
the study period were probably due to the suppression of insulin release H o w -
ever, the glycemia did not seem to have an important effect on BP, since at 60 mm, 
when the BP fall was maximal, the mean plasma glucose levels did not differ signi-
ficantly from those after placebo treatment in the two groups. 
Plasma insulin concentrations were significantly lower after octreotide admini-
stration, as also found in other studies [11] Intravenous insulin administration 
has been reported to cause a decrease in BP as well as hypotension and syncope in 
diabetic patients and patients with autonomic failure [9,26,27]. Furthermore, our 
earlier finding that BP in the elderly decreased after oral glucose, but not after oral 
fructose [5] suggested that insulin plays a role m postprandial blood pressure 
reduction Octreotide may, therefore, exert its beneficial effect by inhibiting insu-
lin secretion 
Several subjects reported abdominal discomfort after the study, and similar side-
effects were reported in another study [11]. Perhaps these side-effects are related 
to the marked effect that somatostatin has on gut motility [28], which was 
recently also found for octreotide [29] 
In conclusion, our data indicate that 50 /u.g octreotide, given sc before oral glucose 
administration, completely prevent the glucosemduced decrease in BP in normo-
and hypertensive elderly subjects. Thus, treatment with octreotide holds promise 
for patients with symptomatic postprandial hypotension VIP does not seem to 
play a role in the etiology of postprandial hypotension in the elderly The benefi-
cial effects of octreotide may be due to a direct effect on the splanchnic circula-
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tion, effects on the secretion of other vasoactive gut hormones, or inhibition of 
insulin release 
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CHAPTER Vili 
Influence of octreotide (SMS 201-995) and 
insulin administration on the course of 
blood pressure after an oral glucose load in 
hypertensive elderly subjects 
Abstract 
Pretreatment with a somatostatin analogue octreotide (SMS 201-995) prevents 
postprandial blood pressure reduction (BP) in the elderly. We hypothesized that 
this beneficial effect on BP is caused by an octreotide-induced suppression of 
insulin secretion. In 10 healthy hypertensive elderly persons (mean age 73 ± 3 
years), we studied the effects of octreotide and insulin administration on the 
course of BP after oral glucose loading. Octreotide was given in a dose of 50 μζ sc 
(time —30 min). Insulin was given sc in a dose of 0.3 U/kg bodyweight (time — 10 
min) and glucose was given orally in a dose of 75 gram in 300 ml water (time 0 
min). Plasma insulin concentrations essentially remained unchanged after placebo 
and rose to a maximum level of 58 ± 6 mU/1 following insulin administration. 
The course of BP following glucose loading with high or low plasma insulin levels 
was not different between both tests. These data indicate that the effects of octreo­
tide on postprandial BP reduction in the elderly is unrelated to the inhibition of 
insulin secretion. 
Introduction 
It has been demonstrated that blood pressure (BP) in the elderly and in patients 
with autonomic failure may fall after a meal [1,2,3]. The mechanism of postpran­
dial BP reduction is unknown but it has been proposed that both an impaired 
sympathetic reflex reactivity to splanchnic vasodilation and interference of insulin 
with a normal function of the sympathetic nervous system might be responsible 
[1,4]. The suggestion that insulin plays an important role in postprandial BP 
reduction is based on the following findings. Firstly, in previous studies we found 
that BP of elderly persons decreases after oral glucose loading, but not after oral 
fructose loading [4]. Secondly, preliminary data of our laboratory have shown 
that BP falls after oral glucose but not after oral fat, protein or water loading. 
Finally, intravenous insulin has been reported to cause a decrease of BP and even 
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syncope (not related to hypoglycemia) in diabetic patients and in patients with 
autonomic failure [5,6,7]. 
Pretreatment with a somatostatin analogue octreotide (SMS 201-995) completely 
prevents the fall of BP after oral glucose and we suggested that octreotide may 
exert this beneficial effect by suppression of insulin secretion [8]. Therefore we 
designed the present study to investigate the hypothesis that an inhibition of insu-
lin by octreotide can prevent the BP reduction, induced by oral glucose loading, 
in healthy hypertensive elderly subjects. We studied hypertensive elderly persons 
since the decrease of BP after an oral glucose load is related to baseline BP [2,4]. 
Methods 
Ten hypertensive elderly subjects (7 men, 3 women) were recruited by a newspa-
per announcement. Antihypertensive drugs were withdrawn for at least two 
weeks before the study. The mean age of the subjects was 73 ± 3 (SD) years (range 
71 - 81) and the Quctclct index was 26.1 ± 2.6 (SD) kg/m2. The supine BP after 5 
minutes rest measured with a standard sphygmomanometer was 181/99 ± 19/11 
(SD) mm Hg. None of the subjects had a history of myocardial infarction, cere-
bro-vascular accident, congestive heart failure or diabetes mellitus. The study was 
approved by the local ethical committee and all subjects gave written informed 
consent. 
All studies were carried out in the morning after an overnight fast. During the 
study the subjects stayed in the supine position. At time 0 min the subjects consu-
med 75 gram glucose in 300 ml water within 5 minutes. Injections of octreotide, in 
a dose of 50 /u.g were given subcutaneously in the upper leg, '/0 min before the 
intake of glucose. Insulin (Actrapid H.M. Penfill® 0.3 U/Kg bodyweight) or pla-
cebo (Penfill Test Medium containing phenol 3 mg, glycerol 24 mg and water for 
injection to 1.5 ml) was injected subcutaneously in the abdomen using an insulin 
pen (NovoPen®, Novo Industri, Bagsvaerd, Denmark). Injections were given in a 
randomized order 10 minutes before the glucose load. Oral glucose loading, after 
insulin or placebo, was performed in each subject with an interval of at least three 
days. 
BP was measured with an automatic recorder (Arteriosonde 1225, Roche) and 
heart rate was calculated from an ECG-recording at 5 min intervals from —10 to 
120 min. Before the injections of octreotide, three BP- and heart rate measure-
ments, taken after 30 min of rest, were averaged and considered as the baseline BP 
and heart rate. A 21 gauge butterfly needle was inserted 30 min before the start of 
the test in an antecubital vein and kept patent with a 154 mmol/1 NaCl solution. 
At times —30, —10, 0 and at every 15 min afterwards until time 120 min, blood 
samples were collected for measurement of glucose and insulin. Blood glucose 
was estimated using a Reflolux® glucose analyzer (Boehringer Mannheim BV, 
Almere, The Netherlands), immediately after drawing the blood sample. When 
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plasma glucose levels fell below 3 mmol/1 the test was brought to an end. Plasma 
glucose values, as given in this study, were measured with an autoanalyzer, using 
the glucose oxidase method. Plasma insulin was measured in duplicate using a 
radioimmuno assay. 
Statistical comparisons between paired and unpaired observations were made 
with Student's t-test when appropriate; otherwise Wilcoxon's signed rank and 
ranked sum tests were used. To reduce the overall probability of a type I error, a 
level of significance of p £ 0.01 (two-sided) was employed. Comparisons between 
curves were made with a distribution-free analysis of variance [9]. In this test a p-
level of 0.05 or less was considered to be statistically significant. Mean arterial 
pressure was calculated as the sum of diastolic BP and one third of pulse pressure. 
All values given in tables and text are expressed as mean ± SEM, unless indicated 
otherwise. 
Glucose (mmol/1) 
Insulin (mU/U 
8 0 - , 
^ 1 1 1 1 1 1 1 1 1 r^ 
Baseline -10 0 30 60 90 120 
Time (mm) 
Figure 1 Plasma glucose and insulin levels before and after oral glucose (G). 
S indicates pretreatment with 50 μg octreotide sc and I insulin or placebo admini­
stration 
denotes p<0.01 and "' ' p<0.001 when compared with baseline values whereas 4 
means / J < 0 . 0 1 and + + means p<0.00l compared with values at time 0 mm. 
101 
Results 
The course of plasma glucose and insulin levels are depicted in Fig 1 In three 
patients the study with insulin pretreatment was stopped at time 105 mm because 
plasma glucose levels fell below 3 mmol/1 Octreotide resulted in a significant 
decrease of plasma glucose and insulin levels at time —10 and time 0 mm After 
previous placebo administration, oral glucose resulted in a slow rise of plasma glu­
cose with a maximum of 12 1 ± 10 mmol/1 at time 120 min In contrast, after 
insulin administration, plasma glucose levels remained unchanged Comparison 
of the curves of glucose responses revealed a highly significant difference 
(p=0 006) In the placebo test, octreotide suppressed the insulin response follo­
wing glucose loading Only at the end of the study period, a slight increase of 
insulin was found The mean doses of insulin administered was 23 4 ± 1 1 units 
with a range of 18— 28 After the injection of insulin, plasma insulin concentra­
tion increased to 54 ± 6 mU/1 at time 60 mm with a plateau level until time 120 
mm Both plasma insulin curves were significantly different (p^0 001) 
Fig 2 represents the course of mean arterial pressure and heart rate after both pla­
cebo and insulin administration In both tests BP increased significantly within 20 
Mean arterial pressure (mmHg) 
KO η S I G 
1 1 ί 
« insulin 
о placebo 
100 
Heart rate (beats/mm) 
70-
60-
50-
40 
t-4 
Baseline 10 0 30 60 90 120 
Time (mm) 
Figure 2 Mean arterial pressure and heart rate before and after oral glucose (G) 
S indicates pretreatment with 50 μg octreotide sc and I insulin or placebo admini­
stration 
denotes p<0 01 and /><0 001 when compared with baseline values whereas 
+ means p<0 01 compared with values at time 0 mm 
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min after octreotide administration. Systolic BP increased from 170 ± 7 to 174 ± 
7 mm Hg (not significant) before injection of insulin and from 168 ± 7 to 177 ± 6 
mm Hg (p=0.03) before placebo. Diastolic BP increased from 96 ± 3 to 102 ± 3 
mm Hg (p=0.002) and from 94 ± 3 to 98 ±4 mm Hg (p=0.006), respectively. 
After the glucose load no change in BP was found in either group. Calculation of 
the 95% confidence limits demonstrated no difference between the effects of pla-
cebo and insulin. 
In both tests, heart rate decreased significantly after octreotide, and prior to the 
glucose load. After the intake of glucose there was a slight increase of heart rate 
not exceeding baseline levels. In the placebo group, only at time 120 min, the 
increase of heart rate was significant when compared with the value at time 0 min. 
No difference between the effects of insulin and placebo was found when compa-
ring the 95% confidence limits. 
Discussion 
The present study confirms the beneficial effect of octreotide on the fall in BP, 
induced by oral glucose, in hypertensive elderly subjects. After placebo admini-
stration plasma insulin concentrations were significantly suppressed by octreotide 
whereas, after the injection of insulin, the levels of plasma insulin following oral 
glucose were comparable to those found previously in the elderly [4,8]. The 
course of BP was not different between the tests with high or low plasma insulin 
levels. This clearly demonstrates that the effect of octreotide is unrelated to its 
inhibition of insulin secretion. Studying two patients with autonomic neuropa-
thy, Hoeldtke et al found that insulin, administered simultaneously with octreoti-
de, prevented postprandial hypotension as effectively as when no insulin was 
administered [10]. 
The present study shows that in both test conditions BP increases after octreotide 
administration. We previously reported that octreotide had no influence on BP 
and heart rate in normotensive elderly subjects [8], as was also found in young 
volunteers [11]. Apparently, octreotide has an effect on BP in hypertensive 
elderly subjects. Furthermore, preliminary data of our laboratory and other stu-
dies have demonstrated that BP in patients with autonomic neuropathy also 
increases after octreotide administration [10,12,13]. A possible explanation for 
this pressor effect may be its direct vasoconstrictive effect on splanchnic hemody-
namics, causing a redistribution of blood flow from the splanchnic to the central 
circulation [8,14]. On the other hand, octreotide may raise BP by increasing the 
release of plasma norepinephrine [12]. It can, therefore, be argued that hyperten-
sive elderly and patients with autonomic failure are more sensitive to the pressor 
effect of octreotide, as was found for a variety of drugs in patients with autonomic 
neuropathy [15]. During the first period after octreotide administration we found 
a small but significant decrease of heart rate. To our knowledge no cardio-inhibi-
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tory effects of octreotide have been reported. So, the decrease of heart rate may be 
compensatory to the increase of BP. 
One precaution has to be taken into account with respect to the conclusion that 
suppression of insulin does not contribute to the prevention of BP reduction after 
octreotide and oral glucose loading. A potentially hypotensive effect of insulin 
may have been overruled by the pressor effect of octreotide. Insulin may have 
vasodilating effects. In patients with chronic autonomic failure and in diabetic 
patients, intravenous insulin administration caused a decrease of BP [5,6,7]. Sever-
al studies demonstrated that insulin infusions resulted in a vasodilator effect in 
dogs and healthy man [16,17,18]. Since in the present study BP curves during high 
and low plasma insulin levels were similar, an insulin-induced vasodilation, if 
existing at all, apparently does not play an important role. In addition, in an ear-
lier study we did not find any change in BP after intravenous glucose administra-
tion, although plasma insulin concentrations levels were comparable to those 
found after oral glucose loading [19]. 
Another explanation for the effect of octreotide on postprandial BP reduction is 
an inhibition of vasoactive gut hormones, although attempts to identify such a 
hormone have been unsuccessful [8,10]. Moreover, in a recent study it was 
demonstrated that in young volunteers superior mesenteric artery blood flow 
increased to the same extent after carbohydrate, fat and protein meals [20]. These 
findings suggest that an inhibition of vasoactive gut peptides by octreotide is not 
involved in its effect on BP. 
Although the clinical importance of postprandial hypotension remains to be elu-
cidated, severe dizziness, visual disturbances and syncope simultaneously with 
large falls in BP were reported [3,21,22,23]. Furthermore, Hoeldtke et al descri-
bed three patients who were unable to stand after eating [10]. In the elderly and in 
patients with autonomic failure treatment with octreotide prevents the fall of BP 
after oral glucose or after meals [8,10]. Therefore, octreotide may be of value in 
the treatment of symptomatic postprandial hypotension. Caffeine, was also used 
in the treatment of postprandial hypotension [24,25] but the pressor effect of caf-
feine was not as consistently effective as octreotide [10]. 
In conclusion, our data indicate that in hypertensive elderly subjects BP does not 
change after an oral glucose loading test with pretreatment of octreotide and insu-
lin. The beneficial effects of octreotide on postprandial hypotension therefore 
seems unrelated to its suppression of insulin release. 
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Summary 
Postprandial blood pressure reduction in the elderly has not yet been studied 
extensively. After the first report of Lipsitz et al in 1983, which demonstrated that 
in institutionalized ill elderly subjects on chronic medication systolic blood pres-
sure may decline after a meal. Westenend et al reported that a fall in blood pres-
sure after a meal can also be found in healthy, community-dwelling elderly per-
sons. In this group systolic blood pressure decreased by 7% and diastolic blood 
pressure by 14% at 50 minutes after the start of a breakfast. The occurrence of 
postprandial blood pressure reduction in healthy elderly subjects was subse-
quently confirmed by Lipsitz et al. In young healthy normotensive subjects blood 
pressure remained essentially unchanged after a meal. 
In the first place we investigated whether treatment with antihypertensive drugs 
may cause an increase in the postprandial blood pressure reduction in the elderly. 
An exaggerated fall might be expected from an interference of antihypertensive 
medication with blood pressure homeostasis. In chapter I, however, we report 
that elderly hypertensive patients treated with diuretics, /3-blockers, vasodilators 
or a combination of these drugs, have a similar postprandial blood pressure reduc-
tion as hypertensive elderly without medication. In chapter II we demonstrate 
that antihypertensive treatment with nitrendipine, a new long-acting calcium 
antagonist, or hydrochlorothiazide may even improve blood pressure homeosta-
sis after a meal. In this study we used an oral glucose load instead of a meal in 
order to determine not only postprandial blood pressure reduction but also the 
effects of both treatments on carbohydrate metabolism. After 12 weeks of treat-
ment with both drugs, the percentage changes of mean arterial pressure at 60 
minutes after the glucose load (when the maximal decline in blood pressure was 
found) were significantly smaller in both groups when compared with pretrcat-
ment values. 
The mechanism of postprandial blood pressure reduction in the elderly is un-
known, but an important role for carbohydrates and insulin was proposed by 
Lipsitz et al. They suggested that an age-related decrease of insulin-induced sym-
pathetic nervous system activation may in part be responsible for postprandial 
hypotension. Failure of sympathetic nervous system activation was proposed to 
be mediated by blunting of baroreflex sensitivity by insulin or glucose. To eluci-
date the role of insulin in postprandial hypotension we studied the effects of oral 
glucose and oral fructose loading on blood pressure in chapter III. In contrast to 
an isocaloric, isosmotic and isovolumic glucose load, ingestion of fructose elicited 
only a small increase in plasma glucose and insulin levels. After glucose loading, 
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mean arterial pressure decreased by 17 mm Hg in hypertensive elderly and by 6 
mm Hg in normotensive elderly subjects whereas after oral fructose loading 
blood pressure did not change in both groups. The fall in blood pressure after oral 
glucose starts about 15 minutes after ingestion and reaches its maximum within 
about 60 minutes. The magnitude and time course of the blood pressure reduction 
in normotensive and hypertensive elderly subjects after 75 gram of glucose are as 
much alike as those found after a breakfast containing 49 gram of carbohydrates, 
1.8 gram of fat and 13.4 gram of proteins, as was used in the study described in 
chapter I. These findings give support to the suggestion that the blood pressure 
reduction after a meal is related to glucose. 
In chapter IV we determined whether the hypotensive effects of glucose loading is 
specifically mediated by gastrointestinal factors or by vasodilator properties of 
insulin. In this study we compared the effects of oral versus intravenous glucose 
loading in normotensive and hypertensive old subjects and found that only oral 
glucose loading lowered blood pressure in both groups. After oral glucose loading 
mean arterial pressure fell by 16 mm Hg in the hypertensives and by 8 mm Hg in 
the old normotensives. These data indicate that it is unlikely that a vasodilator 
effect of insulin primarily determines the fall in blood pressure after oral glucose. 
Chapter V describes the results of a study to determine the effects of oral glucose 
loading on baroreflex sensitivity. It has been suggested that eating may affect 
blood pressure homeostasis through an insulin-induced blunting of baroreflex 
sensitivity. In this study we continously measured blood pressure in the finger by 
the Finapres, a new non-invasive blood pressure device. Baroreflex sensitivity, as 
measured by the phenylephrine and nitroglycerin methods, is diminished in the 
elderly, especially in hypertensive elderly subjects. However, glucose loading had 
no influence on baroreflex sensitivity. So we concluded that a further decrease of 
baroreflex function in response to glucose and/or insulin is not involved in the 
etiology of postprandial blood pressure reduction. 
The magnitude of the reduction in mean arterial pressure after the glucose load is 
almost twice as high in the hypertensive elderly as in normotensive elderly per-
sons (chapter III, IV and VII). In addition, in the aforementioned studies, a weak 
but significant relation is found between baseline blood pressure and the reduc-
tion in mean arterial pressure. This relation is in accordance with the decrease of 
baroreflex sensitivity related to age and blood pressure, as was found in chapter V. 
In order to determine whether not only glucose but also other nutrients may 
interfere with postprandial blood pressure homeostasis, we designed a study to 
investigate the effects of glucose, fat, protein and water loading on blood pressure 
in healthy hypertensive elderly subjects (chapter VI). In this study we found that 
blood pressure fell only after oral glucose loading while oral fat, protein and water 
loading had no influence on blood pressure. These results and the findings of 
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chapter III and IV, in which we found that blood pressure only fell after oral glu­
cose, but not after oral fructose or intravenous glucose loading, suggest that oral 
glucose induces a specific splanchnic or systemic vasodilation, possibly mediated 
by vasoactive gastrointestinal hormones. 
The secretion of gastrointestinal hormones (but also of insulin) can be suppressed 
by a long-acting somatostatin analogue, octreotide (SMS 201-995). In chapter VII 
we studied the effects of octreotide on the blood pressure reduction in normoten-
sive and hypertensive subjects aged 70 years or older, after oral glucose in relation 
to plasma concentrations of vasoactive intestinal polypeptide (VIP) and insulin. 
We found that a single subcutaneous injection of octreotide, in a dose of 50 /Ag, 
completely prevents the fall of BP after oral glucose in both groups. Octreotide 
had no effect on plasma VIP concentrations before or after glucose loading. In 
chapter VI we found a significant increase of somatostatin following fat and pro­
tein loading, whereas VIP only increased after fat loading, however, without a 
concomitant decrease of blood pressure. Therefore, we conclude that the data on 
VIP make clear that this peptide does not play an important role in the postpran­
dial blood pressure reduction. However, this does not exclude a role for other 
vasoactive gut hormones such as neurotensin, substance Ρ or bradykinin. 
Other explanations for the effects of octreotide on postprandial blood pressure 
are a suppression of insulin release, as was found in chapter VII, or a vasoconstric­
tive action on splanchnic hemodynamics. To elucidate the role of insulin, we 
investigated the effects of octreotide administration together with insulin or pla­
cebo, on the course of blood pressure after oral glucose loading in ten hyperten­
sive elderly persons in chapter VIII. Insulin was given subcutaneously in a dose 
0.3 U/kg bodyweight and resulted in a mean maximum plasma insulin level of 58 
mU/L. However, the course of blood pressure following oral glucose with high 
or low plasma insulin levels was not different between both tests, which indicates 
that the effect of octreotide on postprandial blood pressure reduction in the 
elderly is unrelated to the inhibition of insulin secretion. 
The cause of postprandial blood pressure reduction remains unresolved. The 
decrease of blood pressure after a meal seems to be related to the ingestion of glu­
cose, but whether vasoactive gut hormones or other glucose related factors such as 
insulin play a causal role, remains open for debate. It is of genuine importance to 
determine superior mesenteric artery blood flow after different nutrients in the 
elderly, since it has been found in young volunteers that superior mesenteric 
artery blood flow increases to the same extent after carbohydrate, fat and protein 
meals. 
The effects of the loading tests on sympathetic nervous system activity can be 
derived from changes in plasma norepinephrine. In this study, plasma norepi­
nephrine rose significantly after oral glucose loading and may therefore reflect 
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activation of the sympathetic nervous system elicited by the fall in blood pressure. 
The increases of plasma norepinephrine in hypertensive elderly subjects were 
equal to or lower than the increases of plasma norepinephrine in normotensive old 
and young subjects, despite a greater fall in blood pressure. This is in accordance 
with the decrease of baroreflex sensitivity related by age and blood pressure. 
However, in normotensive elderly subjects, we also found an increase of plasma 
norepinephrine after oral fructose and intravenous glucose loading, while blood 
pressure remained unchanged. The similar increase of plasma norepinephrine, 
both after oral glucose and fructose loading, indicates that an impairment of an 
insulin-mediated sympathetic nervous system activation does not play an impor-
tant role in postprandial blood pressure reduction in the elderly, as was suggested 
before. In addition to fructose and intravenous glucose loading, ingestion of a fat 
solution, in hypertensive elderly persons, induced increases of plasma norepi-
nephrine, comparable to those found after glucose loading. We conclude, therefo-
re, that the activation of the sympathetic nervous system does not only occur as a 
response to the fall in blood pressure. Non-specific stimuli from the gastrointesti-
nal tract may also contribute to the degree of sympathetic nervous system activa-
tion. 
In conclusion, blood pressure in the elderly may fall after a meal. Antihyperten-
sive treatment may reduce the postprandial fall in blood pressure. Although the 
mechanism is not fully understood, postprandial blood pressure reduction seems 
to be related to glucose related factors, since blood pressure only falls after oral 
glucose loading, but not after oral fructose, fat or protein loading. Vasoactive 
gastrointestinal hormones may play a role in the glucose induced vasodilation of 
splanchnic vasculature, but attempts to identify such hormones were unsuccess-
ful. Therefore we suggest that interference of insulin with a sympathetic response 
diminished by age or desease to splanchnic vasodilation, may be responsible for 
the postprandial fall in blood pressure in the elderly. However, vasodilator effects 
of insulin or a baroreflex response diminished by insulin do not seem to be invol-
ved. Finally, the clinical significance of postprandial blood pressure reduction in 
the elderly, for instance as a cause of falling, remains to be elucidated. 
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Samenvatting 
Postprandiale bloeddrukdaling bij bejaarden is tot op heden nog nauwelijks 
onderzocht. Na het eerste artikel van Lipsitz c.a. in 1983, waarin beschreven werd 
dat bij geïnstitutionaliseerde zieke bejaarden die chronisch medicatie gebruikten, 
de systolische bloeddruk na een maaltijd kan dalen, beschreef Westenend e.a. dat 
ook bij gezonde bejaarde proefpersonen de bloeddruk na een maaltijd dalen kan. 
In deze groep daalde de gemiddelde systolische bloeddruk met 7% en de diasto-
lische bloeddruk met 14% op 50 minuten na aanvang van een ontbijt. Het vóór-
komen van postprandiale bloeddrukdaling bij gezonde bejaarden werd vervolgens 
bevestigd door Lipsitz e.a.. Bij gezonde jonge vrijwilligers bleef de bloeddruk na 
een maaltijd nagenoeg onveranderd. 
Als eerste werd onderzocht of bij bejaarden, die behandeld werden met anti-
hypertensieve medicatie, een grotere daling van de bloeddruk na een maaltijd zou 
optreden. Een grotere daling zou verwacht kunnen worden op grond van interfe-
rentie van antihypertensiva met de bloeddrukregulatie. In hoofdstuk I wordt ech-
ter beschreven dat bij bejaarde hypertensie patiënten die behandeld worden met 
diuretica, beta-blokkers, vaatverwijders of een combinatie van deze middelen, een 
vergelijkbare postprandiale bloeddrukdaling optreedt als bij hypertensieve bejaar-
den zonder behandeling met medicijnen. In hoofdstuk II wordt aangetoond dat 
antihypertensieve behandeling met nitrendipine, een nieuwe, lang werkende cal-
cium antagonist, of hydrochloorthiazide de bloeddrukregulatic na een maaltijd 
zelfs kan doen verbeteren. In deze studie gebruikten wij in plaats van een maaltijd 
een orale glucoscbelasting om naast de postprandiale bloeddrukdaling ook de 
effecten van beide behandelingen op het koolhydraat metabolisme vast te stellen. 
Na 12 weken behandeling met elk van beide medicamenten waren de procentuele 
veranderingen van de gemiddelde arteriële bloeddruk op 60 minuten na inname 
van de glucoseoplossing (het tijdstip waarop de maximale bloeddrukdalingen 
werden gemeten) in beide groepen significant lager dan vóór behandeling. 
De oorzaak van de postprandiale bloeddrukdaling bij bejaarden is niet bekend, 
maar door Lipsitz e.a. werd gesuggereerd dat glucose en insuline een belangrijke 
rol spelen. Zij veronderstelden dat een leeftijdsafhankelijke vermindering van een 
door insuline geïnduceerde stimulatie van het sympatische zenuwstelsel voor een 
gedeelte de postprandiale hypotensie zou kunnen veroorzaken. Vermindering van 
de activering van het sympatische zenuwstelsel zou worden veroorzaakt door een 
verminderde gevoeligheid van de baroreflex ten gevolge van insuline of glucose. 
Om de rol van insuline in de postprandiale hypotensie nader te bestuderen 
werden in hoofdstuk III de effecten van een orale glucose- en een orale fructose-
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belasting op de bloeddruk onderzocht In tegenstelling tot een glucoseoplossing, 
veroorzaakt inname van een fructoseoplossing, met een gelijk volume en een 
gelijke calorische en osmotische waarde, slechts een geringe stijging van de plasma 
glucose en insuline spiegels Na de glucosebelastmg daalde de gemiddelde artende 
bloeddruk met 17 mm Hg in de groep van hypertensieve bejaarden en met 6 mm 
Hg in de groep van normotensieve bejaarden, terwijl de orale fructose belasting 
geen invloed op de bloeddruk had De daling in bloeddruk na de glucosebelastmg 
trad al na 15 minuten na inname van de glucoseoplossing in en bereikt het maxi-
mum na ongeveer 60 minuten. De grootte en tijdsduur van de postprandiale 
bloeddrukdaling na een glucosebelastmg was zowel bij normotensieve als hyper-
tensieve bejaarden ongeveer gelijk aan de bloeddrukdaling na een ontbijt 
bestaande uit 49 gram koolhydraten, 1,8 gram vet en 13,4 gram eiwit, /oals 
gebruikt in de studie beschreven in hoofdstuk I Deze bevindingen ondersteunen 
de suggestie dat de bloeddrukdaling na een maaltijd gerelateerd is aan glucose 
In hoofdstuk IV is onderzocht of de hypotensieve effecten van een glucosebelas-
tmg veroorzaakt worden door maagdarm factoren of door vaatverwijdende eigen-
schappen van de insuline In deze studie werden de effecten van een orale en een 
intraveneuze gluosebelastmg vergeleken bij normotensieve en hypertensieve 
ouderen Alleen een orale glucosebelastmg resulteerde in beide groepen in een 
bloeddrukdaling terwijl de bloeddruk niet veranderde na een intraveneuze gluco-
sebelastmg Na de orale glucosebelastmg daalde de gemiddelde artenele bloed-
druk met 16 mm Hg bij de hypertensieve bejaarden en met 8 mm Hg bij de nor-
motensieve bejaarden Deze gegevens wijzen erop dat een vaatverwijdend effect 
van insuline waarschijnlijk niet de oorzaak is van de bloeddrukdaling na een orale 
glucosebelastmg 
In hoofdstuk V worden de resultaten beschreven van een studie waarin de effecten 
van een orale glucoscbclasting op de baroreflex gevoeligheid onderzocht zijn Er 
is gesuggereerd dat voedselopname de bloeddrukregulatie zou beïnvloeden door 
een door insuline geïnduceerde verminderde gevoeligheid van de baroreflex In 
deze studie werd de bloeddruk continu gemeten aan de vinger met behulp van de 
Finapres, een nieuw, niet invasici bloeddrukapparaat De baroreflex gevoeligheid, 
bepaald met behulp van de phenylephrine en nitroglycerine methode, was volgens 
verwachting bij bejaarden verminderd, met name bij bejaarden met een verhoogde 
bloeddruk Echter, de glucosebelastmg had geen invloed op de baroreflex gevoe-
ligheid Derhalve kan geconcludeerd worden dat een verminderde functie van de 
baroreflex ten gevolge van glucose en/of insuline geen etiologische rol van beteke-
nis speelt bij postprandiale bloeddrukdaling. 
De daling van de gemiddelde artenele bloeddruk na de glucosebelastmg is bij 
hypertensieve bejaarden ongeveer twee keer zo groot als bij normotensieve 
bejaarden (hoofdstuk III, IV en VII) Bovendien wordt er in de reeds eerder 
genoemde studies een significante relatie gevonden tussen de uitgangsbloeddruk 
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en de daling van de gemiddelde arterîele bloeddruk. De7e relatie komt overeen 
met de door leeftijd en bloeddruk verminderde baroreflex gevoeligheid zoals die 
gevonden werd in hoofdstuk V. 
Om vast te stellen of naast glucose ook andere nutriënten een invloed hebben op 
de postprandiale bloeddrukregulatie werden de effecten van glucose, vet, eiwit en 
water op de bloeddruk bestudeerd bij gezonde, hypertensive, bejaarde proefper-
sonen (hoofdstuk VI). Alleen na glucose daalde de bloeddruk terwijl vet, eiwit en 
water geen effect hadden op de bloeddruk. Deze resultaten, alsmede de bevindin-
gen uit eerdere studies (hoofdstuk III, IV en VII), waarin werd aangetoond dat de 
bloeddruk alleen daalde na orale glucose maar niet na intraveneuze glucose of 
orale fructose toediening, wijzen erop dat glucose een specifieke vaatverwijding 
induceert in het maagdarm vaatbed of systemische vaatbed. Mogelijk wordt deze 
vaatverwijding bewerkstelligd door vasoactieve maagdarm hormonen. 
De afscheiding van maagdarm hormonen, maar ook van insuline, kan worden 
onderdrukt door de langwerkende somatostatine analoog octreotide (SMS 201-
995). In hoofdstuk VII werden bij vrijwilligers van 70 jaar of ouder met een nor-
male of verhoogde bloeddruk de effecten van octreotide op de blocddrukdaling na 
een orale glucosebelasting bestudeerd, in relatie tot de plasma spiegels van VIP en 
insuline. In deze studie bleek dat door een eenmalige onderhuidse toediening van 
50 μ octreotide de bloeddrukdaling na de glucosebelasting in beide groepen volle­
dig kon worden voorkomen. Octreotide had vóór noch ná de glucosebelasting 
enig effect op de plasma VIP concentraties. In hoofdstuk VI werd een significante 
stijging van somatostatine gevonden na een vet en eiwit belasting terwijl VIP 
alleen steeg na een vet belasting, echter zonder een gelijktijdige daling van de 
bloeddruk. Concluderend kan gesteld worden dat VIP geen belangrijke rol speelt 
bij de postprandiale bloeddrukdaling. Echter, dit sluit niet uit dat andere vasoac-
tieve hormonen, zoals substantie P, neurotensine of bradykinine mogelijk een rol 
kunnen spelen. 
Andere verklaringen voor de effecten van octreotide op de postprandiale bloed-
drukdaling zijn een onderdrukking van de insuline secretie en een constrictie van 
de arteriën in het maagdarm gebied. Om de rol van insuline nader te bestuderen 
werden in hoofdstuk VIII de effecten bestudeerd van octreotide, met gelijktijdige 
toediening van insuline of placebo, op het verloop van de bloeddruk na een orale 
glucosebelasting bij 10 hypertensieve bejaarde vrijwilligers. Insuline werd subcu-
taan gegeven in een dosering van 0.3 U/kg lichaamsgewicht. Dit resulteerde in een 
gemiddelde, maximale, plasma insuline spiegel van 58 mU/1. Het verloop van de 
bloeddruk na een orale glucosebelasting was echter niet verschillend tussen de test 
met een lage en de test met een hoge insuline spiegel. Dit wijst erop dat het effect 
van octreotide op de postprandiale bloeddrukdaling bij bejaarden niet verklaard 
kan worden door remming van de insuline secretie. 
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De oorzaak van de postprandiale blocddrukdaling blijft onopgelost. De daling 
van de bloeddruk na een maaltijd lijkt gerelateerd te zijn aan de inname van glu-
cose maar of vasoactieve darm hormonen of aan glucose gerelateerde factoren, 
zoals insuline, een causale rol spelen, blijft ter discussie staan. Het is van belang bij 
bejaarden de bloeddoorstroming te bepalen van de arteria mesenterica superior na 
inname van verschillende nutriënten omdat bij jonge vrijwilligers is aangetoond 
dat de bloeddoorstroming van de arteria mesenterica superior in gelijke mate toe-
neemt na koolhydraat, vet en eiwit maaltijden. 
De effecten van de belastingtesten op de activiteit van het sympatische zenuwstel-
sel kunnen worden afgeleid van de veranderingen in de plasma noradrenaline con-
centraties. In onze studies (hoofdstuk III, IV, V and VI) steeg het plasma noradre-
naline significant na de orale glucosebelasting en dit kan derhalve een afspiegeling 
zijn van een activering van het sympatische zenuwstelsel ten gevolge van de daling 
in bloeddruk. De toename van het plasma noradrenaline bij de hypcrtensieve 
bejaarden vrijwilligers was gelijk aan of lager dan de toename van noradrenaline 
bij de normotensieve bejaarde en jonge vrijwilligers, ondanks een grotere daling in 
bloeddruk. Dit is in overeenstemming met de door leeftijd en bloeddruk vermin-
derde baroreflex gevoeligheid. Bij de normotensieve bejaarde vrijwilligers werd er 
tevens een stijging van het plasma noradrenaline gevonden na een orale fructose en 
een intraveneuze glucosebelasting, ondanks het gegeven dat de bloeddruk onver-
anderd bleef. De gelijke stijging van plasma noradrenaline na zowel een orale glu-
cose- als een orale fructosebelasting, wijst erop dat een door insuline bewerkstel-
ligde verminderde activering van het sympatische zenuwstelsel geen belangrijke 
rol speelt in de postprandiale bloeddrukdaling bij bejaarden zoals eerder gesugge-
reerd was. Bovendien veroorzaakt een vet oplossing bij hypcrtensieve bejaarde 
vrijwilligers een stijging van plasma noradrenaline vergelijkbaar met een stijging 
na een orale glucosebelasting. 
Derhalve kan geconcludeerd worden dat de activering van het sympatische 
zenuwstelsel niet alleen veroorzaakt wordt door de daling van de bloeddruk. 
Aspecifieke stimuli van het maagdarm systeem kunnen ook bijdragen tot de acti-
vering van het sympatische zenuwstelsel. 
Concluderend kan men stellen dat de bloeddruk bij bejaarden na een maaltijd kan 
dalen. Wellicht dat antihypertensieve medicatie de postprandiale bloeddrukdaling 
kan verminderen. Hoewel het mechanisme niet volledig bekend is, lijkt de post-
prandiale bloeddrukdaling gerelateerd te zijn aan glucose gezien het feit dat de 
bloeddruk wel na een glucosebelasting maar niet na een orale fructose, vet of eiwit 
belasting daalt. Vasoactieve maagdarm hormonen kunnen een rol spelen in de 
door glucose geïnduceerde vaatverwijding in het maagdarm gebied, hoewel er 
geen dergelijk hormoon geïdentificeerd kon worden. Het lijkt waarschijnlijk dat 
interferentie van insuline met een door leeftijd en ziekte verminderde activering 
van het sympatische zenuwstelsel op de vaatverwijding in het maagdarm gebied 
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een rol speelt in de postprandiale bloeddrukdaling bij bejaarden. Echter, vaatver-
wijdende effecten van insuline of een door insuline verminderde gevoeligheid van 
de baroreflex gevoeligheid spelen waarschijnlijk geen rol. De klinische relevantie 
van de postprandiale bloeddrukdaling bij bejaarden, b.v. als oorzaak voor het val-
len, dient onderzocht te worden. 
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MEALS AND BLOOD PRESSURE 
IN THE ELDERLY 
Experimental studies on postprandial blood pressure reduction 
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Nijmegen, 2 juni 1989 
1. Postprandiale bloeddrukdaling is specifiek gerelateerd aan inname van glu-
cose. Dit wijst erop dat insuline een belangrijke rol speelt in de pathofysio-
logie van dit phenomeen. 
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2. Bij symptomatische postprandiale bloeddrukdaling is een behandeling met 
octreotide (SMS 201-995) te overwegen. 
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3. Voor een goede beoordeling van het effect van antihypertensieve medicatie 
bij ouderen moet de invloed van de maaltijd worden geëlimineerd. 
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5. Orthostatische hypotensie bij ouderen mag nooit uitsluitend aan de leeftijd 
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betahydroxylase een eenvoudige en betrouwbare laboratoriumproef is om 
familiaire middellandse-zeekoorts aan te tonen dient eerst onderzoek verricht 
te worden bij controlegroepen. 
MH Barakat et al. Lancet 1988;11:1280-1283 
7. Het ontbreken van anemie of macrocytose is geen reden om een onderzoek 
naar vitamine B12 deficiëntie achterwege te laten. 
J Lindenbaum et al. N Engl J Med 1988;318:1720-1728 
8. Bij ouderen hebben thia/idediuretica geen invloed op de cholesterol en tri-
glyceride concentraties in het plasma. 
RW M M Jansen et al. Clin Pharmacol Ther 1989;45:291-298 
9. De communicatie tussen artsen en patiënten zou er mee gebaat zijn als artsen 
zouden beseffen dat de meeste patiënten niet langer dan twee minuten het 
woord voeren, althans wanneer men ze zonder interrupties rustig laat uit-
spreken over hun klachten. 
JN Blau. Br MedJ 1989;298:39 
10. Het vermogen om zelfstandig beslissingen te nemen neemt niet noodzakelij-
kerwijs af met de leeftijd. 
JA Barondcss et al.J Am Gcnatr Soc 1988;36:919-937 
11. Wie zegt dat een kunstwerk te snel gemaakt is, heeft misschien te snel 
gekeken. 
Vincent van Gogh, 26-05-1888 
12. Alleen wanneer de te drinken glucoseoplossing ijs- maar dan ook ijskoud is 
vindt er bij ouderen geen bloeddrukdaling plaats. 
H Kuipers, RW M M Jansen, WHL Hoefnagels, eigen waarneming 
13. Uit de "citation index" van stellingen uit proefschriften in het dagblad NRC-
Handelsblad valt af te leiden dat het met de creativiteit van Nijmeegse onder-
zoekers droevig gesteld is. 
14. In de subsidie-aanvraag voor een onderzoeksproject dient een royaal reis-
budget te worden opgenomen. 


ISBN 90-9002885-4 
